nonprofit organization clear mission statement: save life patient blood cancer lifethreatening disease advancing field blood marrow transplantation cell therapy worldwide science, education advocacy. registry, wa established 1974. Shortcuts Search Main navigation Menu unique registry. vibrant scientific community. Fighting life-threatening blood cancer disease improving patients' lives. Science Education Patient Care EBMT Become Member EBMT gain access database kind Europe EBMT News Highlights Patient Care & Donor Information Access variety material information compiled patient donor mind. Fast Facts Patients 702,579 Registry Transplants 826,418 Registry Patients treated CAR T-cells 5,000+ Registry Accreditations 214 JACIE-accredited centre EBMT Partners Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu unique registry. vibrant scientific community. Fighting life-threatening blood cancer disease improving patients' lives. Science Education Patient Care EBMT Become Member EBMT gain access database kind Europe EBMT News Highlights Patient Care & Donor Information Access variety material information compiled patient donor mind. Fast Facts Patients 702,579 Registry Transplants 826,418 Registry Patients treated CAR T-cells 5,000+ Registry Accreditations 214 JACIE-accredited centre EBMT Partners Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Primary tab Username Enter EBMT username. Password Enter password accompanies username. Please, choose service provider. Service provider - Select -MembershipEBMT Organization Secondary 2024 EBMT. right reserved. Footer menu Search Follow Twitter Event landing menu Toggle main menu visibility 50th Annual Meeting EBMT 14-17 April 2024 | Glasgow Celebrating 50 Years Community Attendance 50th Annual Meeting EBMT 2024 opportunity connect cutting-edge scientific content related transplantation cellular therapy, network thousand top healthcare professional world, celebrate remarkable achievement European international transplant community past 50 years.... Join Scientific Community Glasgow Annual Meeting EBMT congress involved care transplant cellular therapy patients. dedicated session physicians, nurses, data managers, statisticians, quality managers, cell therapists, paediatricians, pharmacists, psychologists, psychiatrist psychoanalysts, transplant coordinators, lab scientists, trainees, patients. 5,500+ Expected Attendees 1,000+ Abstract Submissions 100+ Countries Represented Rewatch Congress On-Demand June Missed session presentation? Unlock On-Demand Content 50th Annual Meeting watch recording via Virtual Meeting Platform EBMT 2024 Appuntil 17 June 2024 23:59 CEST. Download Official EBMT 2024 App EBMT 2024 App best tool help enjoy 50th Annual Meeting mobile device. Click download Apple App Google Play stores! Explore Scientific Programme Local Organising Committee, together EBMT Scientific Council, ha designed outstanding programme cover key issue relating HCT cellular therapy research. Watch EBMT TV's Daily Episodes Interviews EBMT TV produced daily episode 50th Annual Meeting featuring conference news in-depth report collaboration international film broadcasting company WebsEdge. Visit EBMTs YouTube channel (@TheEBMT) watch episode interviews. Learn Annual Meeting Annual Meeting EBMT ha rich history 49 years. celebrate 50th anniversary Annual Meeting Glasgow Scottish Event Campus. Learn congress venue Annual Meeting clicking below. Quick Links Read latest EBMT 2024 news Certificate Attendance CME Points Certificate Attendance Certificate Attendance available within Virtual Meeting Platform sent via email participant attended congress final day 50th Annual Meeting (Wednesday, 17 April 2024). order download Certificate Attendance, kindlyask complete short satisfaction survey. recommend complete survey using computer order download Certificate Attendance successfully. EBMT issue certificate last five editions. information, contact secretariat@ebmt.org CME Accrediation programme 50th Annual Meeting EBMT, held Glasgow, United Kingdom, 14 - 17 April, 2024, ha reviewed andapprovedfor CME accreditation European Board Accreditation Hematology (EBAH) CME Unit. EBAH-CME Unit ha approved educational activity maximum number of26.5EBAH-CMEcredit pointsand time spent participant educational activity tracked purpose. participant may print EBAH-CME certificate, indicating number EBAH-CME credit point awarded, directly CME section EBAH website at. EBMT certifies content CME event without advertisement content presented scientifically neutral. certify speaker author disclose potential conflict interest appropriately. Watch On-Demand Content 50th Annual Meeting watch recording via Virtual Meeting Platform EBMT 2024 App. Thank interest 50th anniversary! Please note session presentation pending review speaker may consent publication content on-demand. platform on-demand content remain available 17 June 2024 23:59 CEST. Download Official Annual Meeting App best tool help plan day 50th Annual Meeting. inside app access virtual meeting platform well as: Easily save session create personal daily agenda. Receive reminder upcoming presentations. Browse scientific programme, ePosters, faculty, exhibitors, sponsors, floor plan more! Post Memories Social Media #EBMT24 Share favourite moment 50th Annual Meetingand add conversation social media! Include #EBMT24 tag @TheEBMT posts. Check Meeting Organisers EBMT Executive Office +34 93 453 8570 CME Congresses Useful Links Stay Updated Subscribe News & Updates list get latest information 50th Annual Meeting EBMT news events. 2024 EBMT. right reserved. Shortcuts Search Main navigation Menu Breadcrumb EBMT Registry EBMT Registry, established 1974, backbone EBMTs research educational activities. provides pool data haematopoietic cell transplantation (HCT) healthcare professional perform studies, ass epidemiological trends, ultimately improve care patient haematological malignancy life-threatening disorders. 2023, EBMT Registry ha acquired data 700,000 patient received HCT procedure well data 4,000 patient received CAR T-cell therapy. thanks reporting done members, order retain full EBMT membership status, must report consecutive HCTs year. EBMT Registry contains patient clinical data, including aspect diagnosis disease, first-line treatments, HCT cell-therapy-associated procedures, transplant type, donor type, stem cell source, complication outcome. Patients followed indefinitely. Basic donor information included procedures, donor follow-up data entered transplant centre (or Donor Registry, unrelated donors). EBMT Registry study performed supervision EBMT Working Parties. EBMT Membership EBMT member centre access EBMT Registry. Find centre become member EBMT. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / Working Parties 11 Working Parties body whose mission implement EBMT's Scientific Educational policies. Together Data Offices, develop manage scientific proposals, also contribute definition guideline policies. support Executive Office, Working Parties key driver developer educational activity offered EBMT. majority Parties disease-based, also several transversal group cover multiple diseases. Learn Working Parties clicking link below. interested work Nurses Research Group, click link bottom page. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb JACIE Accreditation Joint Accreditation Committee ISCT-Europe & EBMT (JACIE) Europes official accreditation body field haematopoietic cell transplantation (HCT) cellular therapy (CT). promotes high-quality patient care medical laboratory practice profession-led, voluntary accreditation scheme. JACIE activity since 2002 Total initial application 511 accreditation Total inspection 395 initial accreditation Total inspection 377 reaccreditation Countries: Centres 35 country applied Current valid accreditation 256 awarded institution Inspections preparation 149 . Members EBMT eligible 50% discount accreditation fee JACIE News Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb COVID-19 BMT context coronavirus disease (COVID-19), EBMT ha set section provide array useful information resources. EBMT Recommendations Due fast spreading SARS-CoV-2 panel expert EBMT recommends following guideline transplant units, recipients, donor hematopoietic cells. guideline updated new information obtained COVID-19 epidemiology clinical outcome. Working Parties' recommendation working party download Infectious Diseases Working Party Recommendations regarding pre-therapy positivity SARS-CoV-2 Severe Aplastic Anemia Working Party Autoimmune Diseases Working Party; Infectious Diseases Working Party; Paediatric Diseases Working Party; JACIE Committee; Nurses Group; Patient Advocacy Committee Acute Leukaemia Working Party EBMT COVID-19 Task Force EBMT COVID-19 Task Force wa created support patient EBMT Community throughout COVID-19 pandemic. goal tackle different aspect pandemic: infectious issues, non-infectious complications, donor organisational issues, organisation outpatient clinic ward including medical nursing activities, quality (JACIE) educational activities. structure Task Force consists transversal participation across different EBMT Groups Committees. Two coordinator IDWP chair leading group, along representative the: Executive Committee representative IDWP TCWP Working Parties Chairs since complication SARS-CoV-2 implicate two WPs directly additional WP Chairs ALWP, CTIWP, LWP, CMWP, ADWP, IEWP, SAAWP PDWP JACIE Committee Nurses Group Executive Office representative education activity Donor Outcomes Committee COVID-19 Task Force Studies Publications JACIE FAQ COVID-19 implication accreditation process inspection wa scheduled cancelled COVID-19 interrupted normal services. inspection rescheduled? scheduling on-site inspection safe return on-site visits. JACIE continues monitor situation recently started reach inspector network national representative ass condition country centre preparing accreditation. working basis able resume least activity autumn give user horizon fix. Needless say, safety volunteer inspector priority willingness travel availability key able form team agree date centres. reason, kindly ask centre flexibility patience complex task reactivation support inspector necessary safety measures. case cancelled inspections, JACIE make every effort assign inspection team inspector already made preparation on-site visit. pre-inspection phase accreditation process. do? Centres continue submit document maintain correspondence assigned Accreditation Coordinator. Accreditation Coordinators available email teleconference (on request) assist you. JACIE understands situation affect centre preparation offer flexibility regard timeline please notify Coordinator anticipate delays. Note process take longer expected, centre may asked update information provided earlier provide updated version documentation order inspector recent information related files. happens accreditation expires? Centres whose accreditation expired 31 March 2020 automatically received 12-month extension accreditation cycle notified early April email. Accreditations already expired 1 April 2020 extended. centre submitted application accreditation listed "In Process" separate list Accredited centres. referred "coverage", term limited acknowledging given centre accreditation process without yet achieved accreditation. letter effect requested centre writing . JACIE website official source list Accredited Centres Centres Process. See www.ebmt.org/jacie-accredited-centres details. cases, centre may appear list recent accreditation still force submitted application renew accreditation e.g. accreditation expiring December 2020 application reaccreditation submitted December 2019. centre wish proceed new application. case, JACIE encourages early application reaccreditation (at least 12 month expiry earlier possible) avoid minimise gap accreditations. Centres expired accreditation award listed. letter confirmed previous accreditation award provided upon request. Due pandemic, make temporary change set-up processes. need report JACIE? JACIE aware centre may move patient change service temporarily due current extraordinary circumstances. change require immediate reporting JACIE approval. Nonetheless, change occurring centre currently accredited reported JACIE soon possible using Changes affecting Accreditation Report document found https://www.ebmt.org/ebmt/documents/changes-affecting-accreditation-report. report provided inspector next inspection. Centres apply quality management principle change including risk assessment appropriate mitigation identified risk extent possible. definition, change represent deviation normal procedure practice follow internal process planning approving reporting documenting unplanned. Standards B/C/D4.12 B/CM/C/D5.7 apply. Regarding change patient care, centre directed EBMT COVID-19 resource page guidance recommendation EBMT organisation collated. See already accredited. receive certificate ? Due COVID-19 pandemic, activity JACIE office affected. currently possible print certificate official stamped paper. expected resolved coming week staff return office. PDF accreditation letter provided email meantime. Please contact Accreditation Coordinator requests. centre ha already inspected waiting inspection report. demonstrate applied re-accreditation? COVID-19 ha impacted activity inspector Office, may lead delay inspection reports. Centres ask letter JACIE stating centre process JACIE accredited. query please contact: centre ha go Interim Audit (IA) year. interim audit postponed? centre due send IA document 2020, process remain scheduled. audit document-based, centre still present documentation focused quality management aspects. JACIE office send inspector review. kindly reminded interim audit due month obtained accreditation.If centre requires extra time gather document please contact , extend deadline month required. required document found : Novel coronavirus additional information following resource updated regularly timely information: International & European authority (WHO) (CDC) (ECDC) European Commission ha clarified free circulation within EU crucial (EUnetHTA) ECDC ha published Epidemiology website Scientific society (ASTCT) (ASH)(ASCO) (NCCN) (EHA) (BSBMTCT): recommendation COVID Adult BMT (GETH) (SFGM-TC) : Coronavirus stem cell transplant (WMDA) (NICE):Rapid NICE Guideline COVID-19 HSCT Scientific Journals : collection article resource Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, commentary. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT EBMT non-profit medical scientific organisation established 1974 host unique patient registry providing pool data perform study ass new trends. aim connection patients, researcher stakeholder anticipate future cellular stem cell-based therapies. community healthcare professional focused innovation, research advancement field save improve life patient blood-related disorders. EBMT Follow u Social Media Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / EBMT community healthcare professionals, involved clinical blood marrow transplantation cellular therapy, share experience develop co-operative studies. EBMT ha governing body called Board Association three set group channel society's research aim activities: EBMT Working Parties, Committees, Nurses Group, address issue within field specifically related nursing. Learn group below. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT Board Association Board Association administrative body responsible defining strategic direction EBMT running operation decision due taken General Assembly. responsibility include: Defining Strategic Plan EBMT approval GA Approving Plan Annual Budget Supervising Executive Committee Implementing decision regarding Plans Budget Board Association Members Executive Committee Anna Sureda EBMT President Congress Co-President Barcelona, Spain Raffaella Greco EBMT Secretary Italy Mette Hazenberg EBMT Treasurer Netherlands Mirjam Steinbuch EBMT Executive Director Utrecht, Netherlands Scientific Council Chair Vice-Chair Fabio Ciceri Scientific Council chair Research Sciences portfolio ALWP Chair Congress Co-President Milan, Italy Donal McLornan Scientific Council co-chair Research Sciences portfolio CMWP Chair United Kingdom Scientific Council Representatives Antonio Risitano SCIENTIFIC COUNCIL representative Registry portfolio SAAWP Chair Italy Annalisa Ruggeri SCIENTIFIC COUNCIL representative Education portfolio CTIWP Chair PRACTICE HARMONISATION COMMITTEE VICE-CHAIR Italy President EBMT Nurses Group Michelle Kenyon President Nurses Group United Kingdom Hilda Mekelenkamp President-Elect Nurses Group MEMBER NG SCIENTIFIC COMMITTEE Netherlands Co-Presidents 51st Annual Meeting EBMT Anna Sureda EBMT President Congress Co-President Barcelona, Spain Fabio Ciceri Scientific Council chair Research Sciences portfolio ALWP Chair Congress Co-President Milan, Italy Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Scientific Council - Working Parties Scientific Council defines scientific education policy EBMT approved General Assembly. member consist Chairs 11 Working Parties Nurses Group President. responsibility include: Drafting scientific educational policy EBMT preparing General Assembly approval; Regularly evaluating scientific educational activity Working Parties; Advising Board scientific educational issues. Scientific Council Members Fabio Ciceri Scientific Council chair Research Sciences portfolio ALWP Chair Congress Co-President Milan, Italy Antonio Risitano SCIENTIFIC COUNCIL representative Registry portfolio SAAWP Chair Italy Tobias Alexander ADWP Chair Germany Donal McLornan Scientific Council co-chair Research Sciences portfolio CMWP Chair United Kingdom Annalisa Ruggeri SCIENTIFIC COUNCIL representative Education portfolio CTIWP Chair PRACTICE HARMONISATION COMMITTEE VICE-CHAIR Italy Bndicte Neven IEWP Chair France Dina Averbuch IDWP Chair Israel Zinaida Peri TCWP Chair Acute Lymphoid Leukaemia Subcommittee Croatia Ali Bazarbachi LWP Chair Member Global Committee Post-transplant pharmacologic modulation subcommittee Beyrouth, Lebanon Krzysztof Kalwak PDWP Chair Poland Emanuele Angelucci HWP CHAIR Italy Michelle Kenyon President Nurses Group United Kingdom Working Parties mission Working Parties implement EBMT Scientific Educational Policy through: elaboration management scientific proposal support Data Offices; elaboration organization educational activity support Executive Office; Contributions development definition guideline policies. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT Committees EBMT Committees established year response various need identified EBMT community span different function EBMT. objective support advise EBMT Board committee management, well Working Parties, carry activities. Learn committee below. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT Board Counsellors Board Counsellors advisory board give input EBMT strategic plan. Members Andrea Bacigalupo Member Board Counsellors Honorary Member Italy Gsta Gahrton Member Board Counsellors Honorary member Sweden Bob Lwenberg Member Board Counsellors Netherlands Mary Horowitz Member Board Counsellors United States Frederick Appelbaum Member Board Counsellors United States J Barrett Member Board Counsellors United States Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT Staff Offices EBMT ha implemented work home policy, therefore, need contact staff member, please complete inquiry. Would like work non-profit organisation make difference? Apply one open staff society . Office Location Barcelona, Spain Edifici Dr. Frederic Duran Jord Passeig Taulat, 116 08005 Barcelona (Spain) EBMT Executive Office Tel: +34 93 453 8570 JACIE Accreditation Office Tel: +34 93 453 8570 Leiden, Netherlands Rijnsburgerweg 10 2333 AA Leiden Netherlands EBMT Finance Office Tel: +31(0)71 526 1444 EBMT Leiden Study Unit Tel: +31 (0) 71 526 1513 Fax: +49 71 149 008 723 EBMT Clinical Study Unit Tel: +31 (0)71 526 5005 Paris, France EBMT Paris Study Unit / CEREST-TC Hpital Saint Antoine 184, rue du Faubourg Saint Antoine 75571 Paris Cedex 12 France Tel: +33 1 71 97 04 85 Fax: +33 1 71 97 04 88 Shanghai, China EBMT Foundation Shanghai Office 507, Block Mingyuan Business Center No. 1199 Fuxing Middle Road Xuhui District Shanghai, China Tel:+86 21 66083918 Executive Office Mirjam Steinbuch EBMT Executive Director Utrecht, Netherlands Isabel Snchez-Ortega Medical Officer Practice Harmonisation Committee Secretary Barcelona, Spain Lissa Perteghella Leadership Support & Internal Communications Coordinator Administrative Support Committees Madrid, Spain Clinical Research & Registry Department Annemiek Markslag Clinical Research Registry Director Registry Committee Leiden, Netherlands Education & Events Department Noemi San Emeterio Education & Events Director Barcelona, Spain Quality Care & Advocacy Department Tuula Rintala Quality Care & Advocacy Director London, United Kingdom Community Relations, Marketing & Communications Department Guillermo Puigvents Community Relations, Marketing & Communications Director Barcelona, Spain Operational Support Department Shanghai Office Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Honorary Members Honorary membership awarded EBMT recognition outstanding contribution BMT field and/or work EBMT. Honorary membership ha also awarded founding member EBMT, past EBMT Presidents upon retirement key opinion leader field bone marrow transplantation, cellular therapy gene therapy. Rainer Storb Honorary member United States Jos Carreras Honorary member Spain Theodor Fliedner Honorary member Pierre Cornu Honorary member Gsta Gahrton Member Board Counsellors Honorary member Sweden Eliane Gluckman Honorary member France Bernhard Kubanek Honorary member Germany EC Gordon Smith Honorary member United Kingdom Dick van Bekkum Honorary member Jon van Rood Honorary member Karl Blume Honorary member Jerzy Holowiecki Honorary member Poland Peter Ernst Honorary member Denmark Ferry Zwaan Honorary member Netherlands Alois Gratwohl Honorary member Co-chair JACIE Committee, 2000-2004 Switzerland Hans-Jochem Kolb Honorary member Germany Ardeshir Ghavamzadeh Honorary member Iran Jean-Luc Harousseau Honorary member France Athanasios Fassas Honorary member Greece Manuel Nicolas Fernandez Honorary member Spain Norbert Claude Gorin Global Committee Chair, Chief Representative EBMT Shanghai Office AUTO-SCT graft composition subcommittee Honorary member Paris, France Boris Labar Honorary member Croatia Hele Everaus Honorary member Estonia Wolfgang Hinterberger Honorary member Shaun McCann Honorary member Massimo Martelli Honorary member Theo de Witte Vice-Chair Myelodysplasia Subcommittee Honorary member Netherlands Tapani Ruutu Regimen-related toxicity supportive care Subcommittee Chair TCWP EBMT Honorary member Finland Christian Gisselbrecht Honorary member France Axel R Zander Honorary member Germany Dean Buckner Honorary member United States Enric Carreras HONORARY MEMBER Spain Ray Powles Nuclear Accident Committee Chair Honorary Member United Kingdom Dietrich Niethammer HONORARY MEMBER Germany Per Ljungman Registry Committee Chair Honorary Member Stockholm, Sweden Mauricette Michallet HONORARY MEMBER France Andrea Bacigalupo Member Board Counsellors Honorary Member Italy Dietger Niederwieser Honorary Member Germany Alejandro Madrigal Honorary Member United Kingdom Ernst Holler Honorary Member Germany Judith Marsh Honorary Member United Kingdom Fred Falkenburg Honorary Member Netherlands Noel Milpied Honorary Member France Didier Blaise Honorary Member France Arnon Nagler honorary member ALWP CHAIR 2014-2018 ALWP Molecular Subcommittee Israel Jane Apperley honorary member Chair JACIE Committee, 2008-2010 United Kingdom Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT Membership EBMT collaborative peer network professional working centre individual field clinical haematopoietic cell transplantation, gene therapy cellular therapy. Together, make membership organisation. EBMT ha 7,200 member 70 countries. Members contribute benefit collective knowledge EBMT ha accumulated within EBMT Registry focus main goal saving life patient blood cancer life-threatening diseases. EBMT Registry backbone EBMTs research educational activities. main purpose Registry provide pool data EBMT member perform study ass new trend BMT, gene therapy cellular therapy. 2024, EBMT Registry ha acquired data 820,000 HSCT procedure well data nearly 5,000 patient received CAR T-cell therapy. thanks reporting done members. Membership Types interested becoming member? Click see summary type membership EBMT offer benefits: Centre Membership benefit Centre Members EBMT centre active field transplantation, gene therapy cellular therapy related kind haematopoietic stem cell immunomodulatory cell organisation involved care donor recipient hematopoietic stem cells. Patient Associations involved field transplantation, gene therapy cellular therapy related kind haematopoietic stem cell immunomodulatory cell interested activity EBMT also become Centre Members. Benefits come membership include: access store retrieve data obtain statistical overviews. Become part one the, initiate and/or participate studies. eligible 50% discount fees. Vote EBMT elections. early bird forever attend .* *Patient associations' benefit. view full list benefit fees. Individual Membership benefit Individual Members within EBMT consist healthcare professional actively involved transplantation kind haematopoietic stem cells, field gene therapy cellular therapy, care donors. Individual Members hold degree (MD, PhD, nursing degree relevant degree assessed case-per-case basis) demonstrate expertise stem cell transplantation, cellular therapy relevant fields. Students, patient patient advocate involved field interested activity EBMT also become Individual Members. Representatives pharmaceutical company corporate enterprise eligible Individual EBMT Membership, become . Benefits come membership include: Continue education member access platform.* early bird forever attend .* Become part one the. Get free online access , official journal EBMT. *Patient patient advocate individual benefit view full list benefit fees. Centre Membership Discover Centre Membership within EBMT. Click see full list benefit fee starting team's application process. Individual Membership physician, nurse healthcare professional great option enhance professional development. View full list benefit fee Individual Members. Apply Centre Individual Membership vibrant worldwide community waiting EBMT. Begin Membership application now. Changes Membership account would like make change membership account, including change contact information, team member information, Principal Investigator centre add new team members, question related membership, visit page. Frequently Asked Questions page find answer popular question get asked come EBMT Membership. Contact u Membership: amendment team composition, question invoice, please contact Membership Assistant at: Registry: help reporting data EBMT Registry specific question regarding registration transplant data data flow please contact EBMT Registry following email: Studies: interested specific study protocols, please contact Chairperson corresponding . find contact detail Directory section website. JACIE Accreditation: require information JACIE Accreditation Programme, wish receive JACIE manual, please contact: Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / EBMT devoted promotion knowledge associated transplantation haematopoietic stem cell immunomodulatory cell donor source donor type including basic clinical research, education, standardisation, quality control, accreditation transplant procedures. Mission, Vision & Values Main Areas Work Society Publications EBMT Organisation publishes number important reference sector. Click learn more. Discover becoming Member EBMT facilitate contribution field HSCT cell therapy Partner & Sister Organizations EBMT involved educational partnership groups, also collaborates ad hoc basis sister organization complementary objective working field. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / Mission, Vision & Values Mission community healthcare professional focused innovation, research advancement cellular stem cell-based therapy save improve life patient blood-related disorders. Vision one leading medical scientific organisation cellular stem cell-based therapies, aim connection patients, scientific community stakeholder anticipate future field. Values Patient-focused HEALTHCARE PROFESSIONALS UNITED COMMON GOAL: HIGH-QUALITY PATIENT CARE EBMTs primary goal improve life patient blood-related disorder research, education advocacy. Reliable ROBUST DATA BUILDS TRUST: work improve quality patient care providing robust reliable real-world patient data underpin quality improvement innovation patient benefit. Innovative EMBRACE CLINICAL RESEARCH, BASIC SCIENCE EDUCATION State-of-the-art practice possible combine three essential elements. EBMT community healthcare professional sharing knowledge experience evolving technology HSCT cellular therapy. Quality-focused PATIENTS LIVES BENEFIT HIGH-QUALITY CARE EBMT actively promotes quality improvement across community. JACIE Accreditation program assures rigorous quality standard clinical laboratory practice. EBMT registry provides central framework data collection, research outcome analysis. Inclusive EBMT EVERYONE COUNTS Everyone contribute EBMT. respectful, representative, diverse open-minded community, know every idea initiative seed progress. Integrity CONDUCT ETHICAL RESPONSIBLE WAYS independent professional community focused providing comprehensive trusted recommendation data analysis member stakeholders. goal improve quality patient care ethical, transparent evidence-based processes. Collaborative STRENGTHENING EBMT MEANINGFUL PARTNERSHIPS EBMT open clinical scientific experience across community, including interaction collaboration fellow societies, healthcare organisation stakeholder involved HSCT cellular therapies. Transparent WELCOMING COMMUNITY OPEN DOORS share knowledge, experience research entire community transparent way. proud show do, it. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / Equality, Diversity & Inclusion (ED&I) EBMT take approach Equality, Diversity Inclusion seriously. believe improving good practice area key unlocking potential contribution work Members staff and, important, critical wider work challenging health inequality patient care. 2021 EBMT developed three-year action plan deliver progress area. internal Taskforce wa set help implement this. June 2021, EBMT Board approved creation EBMT ED&I Committee. EDI outcome reported annually EBMT Board. EBMT believe better delivery time EDI issue critical providing best service worldwide patient community.. Related document Publications News Additional ED&I news information Supplement N Engl J Med 2021 ED&I Committee Silvia Montoto Equality, Diversity & Inclusion (ED&I) Committee Chair United Kingdom John Murray EQUALITY, DIVERSITY & INCLUSION (ED&I) COMMITTEE DEPUTY CHAIR United Kingdom @johnerniemurray Anna Sureda EBMT President Congress Co-President Barcelona, Spain John Snowden Member JACIE Committee United Kingdom Noemi San Emeterio Education & Events Director Barcelona, Spain urea Villar HR Manager Barcelona, Spain Natacha Bolaos PATIENT ADVOCACY COMMITTEE CHAIR Spain @BolanosNat Raffaella Greco EBMT Secretary Italy Ibrahim Yakoub-Agha Practice Harmonisation Committee Chair France @i_yakoub_agha Isabel Snchez-Ortega Medical Officer Practice Harmonisation Committee Secretary Barcelona, Spain Michelle Kenyon President Nurses Group United Kingdom Zinaida Peri TCWP Chair Acute Lymphoid Leukaemia Subcommittee Croatia Nico Gagelmann CO-CHAIRPERSON TRAINEE COMMITTEE INTERNAL MEDICINE TRAINEE Germany @TheEBMT_Trainee @NicoGagelmann Claire Horgan CO-CHAIRPERSON TRAINEE COMMITTEE PAEDIATRIC HAEMATOLOGY TRAINEE United Kingdom @TheEBMT_Trainee @Claire_P_Horgan Ben Summerskill EDI Consultant United Kingdom Nada Hamad EQUALITY, DIVERSITY & INCLUSION (ED&I) COMMITTEE MEMBER Sydney, Australia @nadahamad Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu EBMT Annual Report 2023 Society Anna Sureda EBMT President Foreword EBMT President Anna Sureda reflects EBMT's achievement milestone past year. comprehensive report encapsulates journey towards excellence Science, Education Patient Care. year 2023 marked significant milestone EBMT scientific Society. August 2023, EBMT proudly unveiled official launch new EBMT Registry platform, remarkable accomplishment resulting year dedicated teamwork (co-funded European Union EuroTraCTOR grant). innovative platform replaced ProMISe Castor, thereby enhancing data management practice cohesive user experience. primary objective EBMT Registry remains clear: provide EBMT member pool data perform studies, ass epidemiological trends, ultimately enhance patient outcomes. Close collaboration EBMT national registry ensure alignment need request users. Presently, EBMT Registry contains data 700,000 patient underwent hematopoietic cell transplantation (HCT) procedure 8,000 patient treated CAR T-cells. EBMT's commitment advancing gene therapy strategy recognising growing importance haemoglobinopathy ha led establishment new EBMT Working Party, Haemoglobinopathies Working Party, serf scientific educational umbrella stakeholder interested diseases. activity GoCART Coalition 2023 exceptional, notable increase scientific endeavour evidenced publication two new manuscripts, culmination third edition scientific excellence projects, participation numerous educational activities, active engagement harmonised collection clinical data patient treated gene cellular therapy cell tissue hematopoietic origin support collaborative study regulatory decision-making processes. 2023 edition Annual Meeting held special significance three consecutive year virtual gatherings; welcomed 4,500 attendee person, complemented 1,200 virtual participant representing 100 countries. newly formed EBMT Educational Task Force, established 2023 led Chair Co-Chair Scientific Council, Scientific Council Educational Representative, EBMT Medical Officer, ensures involvement representative Working Parties, Nurses Group, EBMT Trainee Committee, JACIE develop diverse range educational content HCT cellular therapy, well provide resource professional development. Throughout 2023, majority mid-sized small educational event transitioned back in-person formats, attendance figure closely mirroring pre-pandemic levels. Credit due highly organised proactive Trainee Committee, played active role events. Special mention must made EBMT- EHA 5th European CAR T-cell Meeting held Rotterdam February 2023, achieved resounding success, establishing organisation leader hosting significant widely attended conference Europe within field. Furthermore, EBMT ASTCT solidified strategic collaboration education hosting 2nd Joint ASTCT-EBMT Basic Translational Scientific Meeting Sitges, Spain, February 2023, ASTCT-EBMT 6th International Conference Relapse Transplant Cellular Therapy (HSCT) Los Angeles November 2023. event provided excellent platform young researcher trainee present work engage leader field. year 2023 also marked turning point accreditation benchmarking efforts. JACIE received 97 applications, representing approximately 30% increase compared 2022. number inspection conducted rose 77, second-highest JACIE's history (2019: 78 inspections), signalling return pre-pandemic level activity. Moreover, number accredited centre reached 68 past year, compared 15 2022 27 2021. JACIE's robust activity 2023 included organising three training course inspectors, training 55 new inspectors, hosting year-round webinar series, launching new JACIE Inspector Handbook 2023 Annual Meeting, enhancing inspector incentive offering 72 grant JACIE inspector attend 50th Annual Meeting EBMT. Additionally, collaboration Quality Manager Committee, JACIE developed new, online, easily accessible accreditation preparation course aimed boosting confidence centre staff preparing undergoing JACIE inspections. benchmarking project progressed steadily, thanks persistent dedication various stakeholders, release EBMT Benchmarking report covering period 2017 2021 November 2023. tireless effort EBMT Nurses Group evident variety activities. included release 2nd edition EBMT Textbook Nurses, 15th Educational Meeting EBMT Nurses Group, brought together 47 faculty member well patients, nurses, physicians, physiotherapists, engineer academic clinical setting spanning 13 different countries. Furthermore, 2023 saw establishment Nurses Next Generation Group, aimed fostering community early-career Transplant Cell Therapy nurses, launch new EBMT podcast Nurses titled "Blood Matters". extend profound gratitude stakeholders: EBMT Board, chair Working Parties Committees, EBMT centre member individual members, EBMT staff, partners, whose generosity selflessness facilitated remarkable progress 2023. Without unwavering support, none achievement would possible. eagerly anticipate sharing many milestone celebrating EBMTs 50th anniversary exceptional community 2024! meet again! Anna SuredaEBMT President Read Read le EBMT Annual Report 2023 Science Following challenging COVID-19 lockdown period, EBMT ha intensified commitment continually advance delivery excellence scientific research education, traditional necessary face-to-face setting online format... . Working Parties Activity Reports science EBMT Annual Report 2023 Education EBMTs Education Events Department, 2023 wa exciting year, full new projects, first in-person edition Annual Meeting European CAR T-cell Meeting since pandemic. 2023, greatly anticipated new EBMT Registry wa launched, training e-courses National Registries, data managers, EBMT Staff ... . Educational activity EBMT Annual Report 2023 Patient Care & Advocacy Improving care patient critical objective EBMT. believe empowering, advocating amplifying interest patients, survivors, caregiver worldwide. sure catch activity Nurses Group, JACIE GoCART Coalition throughout past year. Patient Care & Advocacy Initiatives Financial Report & Highlights 2023 Never nearly 50 year EBMTs existence financial resilience ha tested past couple years. Major challenge Society imposed SARS-CoV-2 pandemic war Ukraine absorbed without significant impact financial situation... Society Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / Media Corner Media Corner offer journalist latest news last EBMT Annual Meeting, press releases,and press clippings. interested EBMT Newsletters, may access via link press clippings. Press Releases Press Clippings Image Gallery Copyright disclaimer: Please credit EBMT source image. Examples: Photo: EBMT; Image: EBMT. image must used state imply endorsement EBMT EBMT employee process service, used manner might mislead. image used advertising commercial promotion, layout copy must submitted EBMT beforehand approval. Click photo access photo gallery recent Annual Meetings. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Year - -2015201620172018201920202021202220232024 Month - -JanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Area - -EBMT OrganizationResearchRegistry/Data ManagementNurses GroupEventsTraining/EducationAccreditationPatients & DonorsTransplant Activity Survey Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Area - -EBMT OrganizationResearchRegistry/Data ManagementNurses GroupEventsTraining/EducationAccreditationPatients & DonorsTransplant Activity Survey Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Creation year Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / EBMT Partners Partners Excellence Corporate non-commercial Companies non-commercial organization active and/or interested field haematopoietic stem cell transplantation cellular therapy may become Collaborating Partner Excellence. Becoming Partner Excellence allow work collaborate EBMT community different ventures, within specific area interest. support, able invest enhancing registry, data quality scientific studies, improving patient care outcome. Although collaborating partnersdo voting right cannot hold office, enjoy range benefit membership rights.Your Partnership Excellenceagreement EBMT grant eligibility work u personalized project reduced rate. Costs assessed case case basis independent partnership fees. rate locked duration contract, irrespective possible price increases. choose different enrolment plan order make partnership. EBMT aim long-term relation partner excellence order ensure safe development activities. Benefits Corporate Partnership Visibility EBMT Transplant Activity Survey Participation EBMT scientific study Collaboration EBMT expert EBMT Pharma meeting Non-commercial Visibility EBMT report specific subject interest National Health Authority request Collaboration EBMT expert EBMT stakeholder meeting BROCHURES DOWNLOAD EBMT Corporate Partners Excellence Brochure EBMT Non-Commercial Partnersof Excellence Brochure Scientific Partners Organisations active field HSCT cellular therapy may become EBMT collaborator/partner entering ''Memorandum Understanding'' EBMT. MOU facilitate variety mutually beneficial agreements, main aim build network expert and/or center (Doctors, Nurses Data Managers) exchange knowledge experience high quality science project educational event addressing important issue HSCT. Companies may also inquire becoming sponsor Annual Meeting, clinical trials, Working Party events. Partners Distinguished Partners Excellence Long-term Partners Excellence Partners Excellence Non-commercial Partners Excellence Scientific Partners Common representation Substances Human Origin's (SoHO) (CoRe SoHO) Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / GoCART Coalition EBMT co-founder , multi-stakeholder coalition patient representatives, health care professionals, pharmaceutical companies, regulators, Health Technology Assessment (HTA) body reimbursement agencies, medical organisations, collaborating maximise potential cellular therapy manufactured cell tissue hematopoietic origin. News Publications Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Career Opportunities EBMT non-profit organization established 1974. 47 years, ha developed leading scientific society Europe cutting-edge field stem cell transplantation cellular therapy. EBMT ha office based Barcelona, Leiden, Paris Shanghai, currently ha 110 employees. looking join non-profit organisation make difference, apply one open staff society career opportunity posted below: EBMT Staff Vacancies looking job make difference work non-profit? Would like part international organisation cutting edge science? EBMT Society Vacancies society aim connection patients, researcher stakeholder anticipate future cellular stem cell-based therapies. looking position within EBMT Working Party, EBMT Committee EBMT Nurses Group, see below: Acute Leukaemia Working Party (ALWP) Nurse exciting opportunity hasarisen join EBMT working party (WP) nurse. position available within . appointment based 3-year Term. purpose working party nurse promote manage nursing research activity nursing education within Working Party supervision WP lead nurse collaboration EBMT NG Research Scientific committees. Applicants must EBMT member practicing Registered Nurse experience performing research educational initiative order lead project advise / support EBMT nurse members. requirement speak, read write English sufficient fluency able communicate effectively. Access email phone mandatory. Potential candidate working currently within field Haematology Stem Cell Transplant. information, please see role description requirements. Apply interested great opportunity join dynamic team, please send copy CV statement support outlining relevant experience working field Haematology HSCT, together research experience interest wish considered role to: Daphna Hutt, EBMT Nurses Group Secretary: DEADLINE applications: Friday 29 March 2024 midday. Job description Job purpose post holder manage nursing research activity supervision Research Committee (RC), nursing education activity supervision Scientific Committee (SC) within Working Party (WP). expected contribute research education agenda EBMT NG RC, SC Working Party. post-holder offer support guidance development research study educational initiatives, promoting opportunity nursing research within Working Party. Reporting EBMT NG RC, EBMT NG SC, WP Chairperson Main activity promote nursing research strategy awareness within WP carry research adding body knowledge appropriate area make contribution strategic development within EBMT NG RC WP support research collaborative partnerships. support dissemination research finding publication writing, teaching, presentation conference appropriate contribute research within EBMT NG RC WP, collaborating development joint proposal project work promote nurse investigator within research assist development delivery educational initiative promoting nursing issues, line EBMT NG WP appropriate duty determined EBMT NG RC SC Specific requirement post holder would expected present relevant nursing study WP possible collaboration, involved least one WP research project, / actively involved development delivery education project(s) agreed WP Duties responsibility duty responsibility individual ha awarded role Nurse Member outlined below: act link EBMT NG RC, SC WP, leading nurse involvement within research study educational initiative agreed within WP produce submit EBMT NG RC, SC, EBMT NG Board WP, annual report activity undertaken (including research educational activities) produce submit summary WP Meeting communication EBMT NG RC SC. facilitate communication update EBMT NG RC new study within WP potential nursing collaboration Co-operation colleague internally externally EMBT NG RC, SC WP Active participation high quality research Assisting colleague WP develop research nursing perspective appropriate Demonstrate active role within WP, working ambassador EBMT NG, RC SC according Terms Reference. Special condition post holder required attend minimum 3 meeting annually EBMT Annual Meeting (and WP Nurse meeting RC & SC), funded EBMT / EBMT NG WP Meeting (funding requested agreed WP Chair) Nursing Research Day (and WP Nurse meeting RC & SC), funded EBMT NG post holder required attend minimum one WP Educational Event appointment based 3 year Term Office, potential re-nomination maximum 2 terms, i.e. 6 years. Person specification Essential Practicing Registered Nurse Time management skills; work independently, effective prioritization, self-motivation flexibility. Evidence multidisciplinary collaboration Excellent team player Proficiency verbal written communication skill (including English Language) Person specification Preferred Previous experience of; involvement and/or development of, research protocol Previous experience of; involvement and/or development of, educational initiative Preferably educated minimum Masters Level currently undertaking Masters Level Study Infectious Diseases Working Party (IDWP) Nurse exciting opportunity hasarisen join EBMT working party (WP) nurse. position available within . appointment based 3-year Term. purpose working party nurse promote manage nursing research activity nursing education within Working Party supervision WP lead nurse collaboration EBMT NG Research Scientific committees. Applicants must EBMT member practicing Registered Nurse experience performing research educational initiative order lead project advise / support EBMT nurse members. requirement speak, read write English sufficient fluency able communicate effectively. Access email phone mandatory. Potential candidate working currently within field Haematology Stem Cell Transplant. information, please see role description requirements. Apply interested great opportunity join dynamic team, please send copy CV statement support outlining relevant experience working field Haematology HSCT, together research experience interest wish considered role to: Daphna Hutt, EBMT Nurses Group Secretary: DEADLINE applications: Friday 29 March 2024 midday. Job description Job purpose post holder manage nursing research activity supervision Research Committee (RC), nursing education activity supervision Scientific Committee (SC) within Working Party (WP). expected contribute research education agenda EBMT NG RC, SC Working Party. post holder offer support guidance development research study educational initiatives, promoting opportunity nursing research within Working Party. Reporting EBMT NG RC, EBMT NG SC, WP Chairperson Main activity promote nursing research strategy awareness within WP carry research adding body knowledge appropriate area make contribution strategic development within EBMT NG RC WP support research collaborative partnerships. support dissemination research finding publication writing, teaching, presentation conference appropriate contribute research within EBMT NG RC WP, collaborating development joint proposal project work promote nurse investigator within research assist development delivery educational initiative promoting nursing issues, line EBMT NG WP appropriate duty determined EBMT NG RC SC Specific requirement post holder would expected present relevant nursing study WP possible collaboration, involved least one WP research project, / actively involved development delivery education project(s) agreed WP Duties responsibility duty responsibility individual ha awarded role Nurse Member outlined below: act link EBMT NG RC, SC WP, leading nurse involvement within research study educational initiative agreed within WP produce submit EBMT NG RC, SC, EBMT NG Board WP, annual report activity undertaken (including research educational activities) produce submit summary WP Meeting communication EBMT NG RC SC. facilitate communication update EBMT NG RC new study within WP potential nursing collaboration Co-operation colleague internally externally EMBT NG RC, SC WP Active participation high quality research Assisting colleague WP develop research nursing perspective appropriate Demonstrate active role within WP, working ambassador EBMT NG, RC SC according Terms Reference. Special condition post holder required attend minimum 3 meeting annually EBMT Annual Meeting (and WP Nurse meeting RC & SC), funded EBMT / EBMT NG WP Meeting (funding requested agreed WP Chair) Nursing Research Day (and WP Nurse meeting RC & SC), funded EBMT NG post holder required attend minimum one WP Educational Event appointment based 3 year Term Office, potential re-nomination maximum 2 terms, i.e. 6 years. Person specification Essential Practicing Registered Nurse Time management skills; work independently, effective prioritization, self-motivation flexibility. Evidence multidisciplinary collaboration Excellent team player Proficiency verbal written communication skill (including English Language) Person specification Preferred Previous experience of; involvement and/or development of, research protocol Previous experience of; involvement and/or development of, educational initiative Preferably educated minimum Masters Level currently undertaking Masters Level Study Scientific Committee EBMT Nurses Group exciting opportunity ha arisen join EBMT Nurses Group. SC collaboration EBMT Nurses Group President President Elect/ Past President, Committees Nurses Groups, aim co-ordinate provide range educational activity nurse allied health professional within field Haematology, Haematopoietic Stem Cell Transplantation (HSCT) immune effector cell therapy. Applicants must EBMT member required speak, read write English sufficiently enough able communicate effectively. Access email phone mandatory. Potential candidate working currently within field Haematology HSCT. Roles responsibility order make team wealth experience ideas, meet face face member committee four time year. EBMT Annual Meeting (March/April) Post congress (May/June) Board & Committees meeting (September/October) Abstract selection meeting (January) also share information update teleconferencing e-mail. committee designates within group task need performed order achieve committee objectives. scientific committee present annual report update activity EBMT NG Board proposal operational expense required. annual report submitted NG Board 1st September discussed annual Board Committees meeting. SC report writing interim update activity EBMT NG board receiving request link person (will requested 2 week prior board meeting). committee designates within group task need performed order achieve committee objectives. member SC play key role organisation EBMT Annual Meeting. involves: Designing program nurse education day main meeting Abstract judging selection oral poster presentation main meeting Allocating space programme symposium sponsored session Apply interested great opportunity join dynamic team, please send copy CV statement support outlining relevant experience working field BMT wish considered role to: Daphna Hutt, EBMT Nurses Group Secretary: DEADLINE applications: Friday 29 March 2024 midday. External Vacancies Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Registry News Registry News Registry Newsletters Press release Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Registry Release Updates EBMT Registry web application data entry take place. web application wa released user August 24th, 2023. release version referred version 1.0. Important information Since latest release EBMT Registry (April 24th, version 2.2), new pop-up seen opening patient ha existing events. popup notify changing field value remove entered data, showing field applicable. pop-up triggered migrated data appears field visible due visibility condition EBMT Registry (e.g. patient dead, see cause death). message ignored pressing 'submit change'. next maintenance mode, take place May 14th-May17th, data restored. Upcoming maintenance mode Due maintenance migration EBMT Registry closed following dates: Dates Reason 14/05/2024 - 17/05/2024 Release analytical tool, solution pop-up appearing 27/08/2024 - 29/08/2024 Migration cycle 4: field failed, ethnicity (UK), postal code (UK FR) 05/11/2024 - 07/11/2024 Extended dataset cycle 1 25/02/2025 - 27/02/2025 Extended dataset cycle 2 Known bug release fix date user started working EBMT Registry, bug reported. resolved already, others pending resolution next release. Issue Fix date Issues saving form checkbox item August 31, 2023 Searching date doe work September 4, 2023 Sorting doe work End September release Issues saving anonymous event August 31, 2023 Errors/warnings appear empty field End September release Typo Ethnicity option Release 1.1 Hint text position misplaced Release 1.1 Events require attention displaying wrong event Release 1.1 Events display attention doe redirect correct event Release 1.1 Fields marked Ongoing/Not Evaluated/Unknown cleared automatically entering data Release 1.1 "Other" could found select-search field Release 1.2 Patients created future Release 1.2 Hidden field activate error/warnings Release 1.2 Endpoint returning error 500 Filter based virtual registry Release 1.4 Donor GRID value upper limit Release 1.4 improvement search Release 1.4 Empty patient page Data Monitors/Viewers Release 1.4 Events clutter timeline Release 1.4 Dashboard displaying wrong information Release 1.5 Patient information variable working filtering Release 1.5 Errors incorrectly triggered date numeric field Release 1.6 Ethnicity question display: "Only UK" Release 1.9 CIC code displayed patient creation Release 1.9 Data viewer able see patient Release 1.9 Release note EBMT Registry ongoing development, new functionality added every while. addition new functionalities, improvement existing functionality bug fix called releases. Version Release date 1.0 August 24th, 2023 1.1 September 26th, 2023 1.2 October 30th, 2023 1.3 October 30th, 2023 1.4 December 4th, 2023 1.5 December 12th, 2023 1.6 January 30th, 2024 1.9 (1.7 + 1.8) March 4th, 2024 2.1 April 22nd, 2024 Version 2.1 release note Release date: April 22nd, 2024. First major update new EBMT Registry. Contains also 2.0 version. Release goals: Implementation versioning system update data capture forms. Data Service versioning system. Dynamic data source linking events. Special status migrated field ensure visibility parent question empty. Discarded field ensure hide non-relevant questions. Version 1.9release note Release date: March 4th, 2024. Releases 1.7 1.8 combined 1.9. Bug fixes: Data editor able update consent sub-questions. Data monitor permission spilling data viewer causing see totality patients. UPN filter improved deal better cap sensitivity. Ethnicity question display disclaimer "UK only". CIC code displayed patient creation. Archival event clearly defined audit trail. Events require attention ha improved reduce number warning triggered. Validations date field updated longer trigger undesired error warnings. Version 1.6 release note Release date: January 30th, 2024 New feature added EBMT Registry: Changing patient data requires reason change. Date informed consent ha updated First date Informed Consent. Bug fixes: Data editor able update consent sub-questions Export button longer greyed number patient export appears Unknown. algorithm used search option dropdown ha update find faster. Validations date field updated longer trigger undesired error warnings. Version 1.5 release note Release date: December 12th, 2023 New feature added EBMT Registry: Filtering special statuses, Evaluated ongoing possible. Bug fixes: Audit trail ha improved increment information available administrators. Filtering patient information variable working expected. Dashboards displayed wrong information cases, ha addressed show correct information. change performed tentative patient check. Version 1.4 release note Release date: December 4th, 2023 New feature added EBMT Registry: Filtering special statuses, Unknown possible. possible add note patients. Centre based virtual registry user create anonymous events. Bug fixes: Endpoint returning error 500 Filter based virtual registry ha fixed. Donor GRID value upper limit wa removed. improvement search implemented. Empty patient page Data Monitors/Viewers display appropiate patients. Events timeline wa re-designed avoid accumulation events. Version 1.3release note Release date: October 30th, 2023 Small improvement 1.2: Data editor update consent status. Version 1.2 release note Release date: October 30th, 2023 New feature added EBMT Registry: Filtering empty fields. Making PDF printable version event. Export functionality data editor data viewers. Maintenance mode EBMT staff change platform migration legacy data safely. Bug fixes: "Other" cannot found select-search field ha addressed. longer possible create patient date event future. Hidden field trigger errors/warnings anymore. Version 1.1 release note Release date: September 26th, 2023 New feature added EBMT Registry: Filtering allows filter centre property CIC (centre identification code) Country. Furthermore, possible filter event without adding extra clause, event creation date. Radio button cleared case erroneous data entry EBMT personnel capability release predefined filter user Centre-based virtual registry allow user see anonymous event associated centre member virtual registry. Improvements EBMT Registry: Demo environment clearly distinguished production avoid entering data wrong section. event overview event require attention redirect relevant event. Bug fixes: Fixed typo ethnicity option Hint text ha positioned appropriately Events require attention longer display event require attention. Furthermore, selecting event require attention redirect user correct event. Fields marked Ongoing/Not evaluated/Unknown clear greyed status automatically data entered without need user click it. Version 1.0 release note Release date: August 24th, 2023 Release tool public Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EuroTraCTOR European Transplant Cellular Therapy Online Registry (EuroTraCTOR) EuroTraCTOR EU grant wa funded EU4Health programme 2021-2027 (grant number 101079887). objective project design, develop implement new EBMT registry improve process collecting using data across EU health systems. EBMT coordinating entity count support 10 project beneficiary 4 external expert organisations. project started end 2022 ha duration 30 months. project constant evolution Hematopoietic Cell Transplantation (HCT) cellular therapy requires continuous development improvement information technology (IT) tool features, prerequisite adjust new innovative treatment associated legal technical requirements. order answer current future need HCT stakeholder Professionals Competent Authorities (CA) EBMT Registry requires significant update structure features. proposed development enable correct monitoring HCT activities, patient donor safety oversight, recording/collecting quality, safety, efficacy data. new EBMT registry built based need identified HCT professional CA aim flexible possible, allowing customization regional/federal level serve adapt different realities, user-friendly manner. future platform aim provide adequate answer requirement clinicians/professionals involved HCT Cellular Therapies one hand stakeholder CA health authority complying best practice associated standardization data protection (General Data Protection Regulation - GDPR), ultimately enabling better health decision leading improved, outcome care EU. Grant detail Call topic: EU4H-2021-PJ-17: Action grant organise collect data understand safety, quality efficacy therapy applied field assisted reproduction based haematopoietic stem cell Budget: 3,3M (2M EU funding) Duration: 30 month Consortium: 11 beneficiaries; 4 external expert entity Coordinator: EBMT Consortium Country Short name Name NL EBMT European Society Blood Marrow Transplantation ES ONT Organizacin Nacional de Trasplantes ISS-CNT Istituto Superiore di Sanit - Centro Nazionale Trapianti DE DRST Deutsches Register fr Stammzelltransplantationen DE UKE Interdisciplinary Clinic Polyclinic Stem Cell Transplantation University Medical Center Hamburg-Eppendorf GITMO Gruppo Italiano Trapianto Di Midollo Osseo FR ABM Agence de la Biomdecine FR SFGM-TC Francophone Society Bone Marrow Transplantation Cellular Therapy NL RADBOUDUMC Radboud University Medical Center ES GETH Spanish Group Hematopoietic Transplantation Cell Therapy BCR Belgian Cancer Registry External experts: Country Short name Name EU EDQM European Directorate Quality Medicines & HealthCare NL ZIN National Health Care Institute - Zorginstituut Nederland CH SBST Swiss Blood Stem Cell Transplantation UK BSBMTCT British Society Blood Marrow Transplantation Cellular Therapy Project plan Co-funded European Union. Views opinion expressed however author(s) necessarily reflect European Union European Health Digital Executive Agency (HaDEA). Neither European Union granting authority held responsible them. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb CAR-T Data Collection Initiative Reporting learning. reporting data patient treated CAR T-cell therapies, contribute academic research regulatory decision making health authorities. Ultimately, support EBMTs mission advance cellular stem-cell based therapy improve life patient blood-related disorders. Data quality fundamental meaningful analyses. ensure complete accurate data, EBMT invite centre treat patient commercial CAR T-cell therapy participate Data Collection Initiativeto support Post Authorisation Safety (PAS) study mandated European Medicines Agency (EMA). Centres participate financially compensated. Data Collection Initiative set support PAS studies? data collection PAS study based standard Registry form procedures, wider infrastructure set-up support PAS study reimburse centre work. Background information approval first CAR-T therapies, EMA required MAHs monitor product long-term. cellular therapy module EBMT Registry received positive qualification opinion EMA, supporting use Real-World Data captured EBMT Registry inform regulatory decision making health authorities. CAR-T therapy promising treatment option many patient haematological malignancies. However, evidence long-term safety efficacy treatment limited. European Medicines Agency (EMA) obliges marketing authorisation holder (MAH, pharmaceutical companies) conduct post authorisation safety (PAS) study monitor long-term safety efficacy CAR-T therapies. PAS study based secondary use EBMT Registry data. 2019 EMA issued positive qualification opinion cellular therapy module EBMT Registry indicating Registry fulfills essential need capture data () early 2020 first PAS study protocol based secondary use EBMT Registry data approved EMAs Pharmacovigilance Risk Assessment Committee. mean normal EBMT Registry form data collection procedure used collect data support regulatory decision making various CAR-T products. important EBMT support PAS study lead Real-World Evidence generation CAR-T therapies. believe reporting learning. centre level, data reporting contribute improved patient management. Moreover, need data centre Europe recorded central, academic registry meaningful analysis contribute global body knowledge CAR-T therapies. informal mantra EBMT Registry, collect data once, use often, also applies CAR-T field. Data wont need reported separate registry owned MAHs EBMT, EBMT. reduces data-entry burden. Moreover, data collection harmonised CAR-T therapies. standard data collection form used currently available CAR-T therapy also used many different CAR-T therapy future. facilitates data entry data comparability. Read Read le Frequently Asked Questions (FAQs) requirement participation Data Collection Initiative? participate Data Collection Initiative CAR-T therapies, centre must, first foremost, report data patient treated (commercial) CAR-T therapy EBMT Registry per standard data collection form process (the Cellular Therapy form). doe require additional contract and/or regulatory approvals. Consequently, data collection already ongoing continue. Secondly, needed, help EBMT Clinical Study Unit obtaining regulatory approval allows patient also consent share data collected Registry EBMTs collaboration partner including MAHs health authorities. Thirdly, (re-)consent patient updated informed consent form. Finally, help set contract centre EBMT allows EBMT reimburse site data management efforts. (See question contract centre sign? below). doe centre participating Data Collection Initiative? need complete standard patient data EBMT Registry August 24 onwards. addition, ask comply data request (queries) ensure completeness quality data. Data patient treated CAR-T therapy need reported following time points: baseline, 100 days, 6 month yearly 15 year passed time 15-year follow-up conducted. Also, ask consent patient , asks patient indicate whether allow sharing data EBMT collaboration partner source data verification data. ly patient explicitly consent share data collaboration partner included dataset shared parties. centre also available on-site monitoring visits. centre participate? me? Participation Data Collection Initiative important reporting learning. PAS study mandated EMA lack information long-term safety efficacy profile CAR-T therapies. prominent European medical community, want lead evidence generation promising treatments. Collectively generate robust real-world evidence support regulatory decision making well scientific studies. current protocol PAS study based secondary use Registry data. approach prevent creation additional database owned marketing authorisation holders. EBMT Registry make data available scientific community avoids need centre report data multiple registries. using harmonised data collection form cellular therapies, easier enter compare data different products. Centres receive generous reimbursement data management efforts. money given patient treated commercial CAR-T therapy (re-)consent sharing pseudonymised data MAHs per Product -Specific Agreement participating site EBMT. good study proposal CAR-T-related study, submit relevant . proposal selected/accepted, access data centre (indirectly) also data centre country Registry whole. Working Parties dedicated statisticians, data manager study coordinator support conduct selected proposals. contract centre sign? contract Data Collection Initiative PAS study split two parts; Data Collection Master Agreement Product- Specific Agreement. Data Collection Master Agreement governs general data collection requirement identical CAR-T therapies. Whereas shorter Product Specific Agreement specifies additional requirement individual CAR-T therapies. new product need sign new Product-Specific Agreement. using set-up, Product-Specific Agreements incorporated Data Collection Master agreement, aim reduce time needed contract negotiation thus reduce start-up timeline burden new cellular therapy product included Data Collection Initiative. also remind centre sign (JCA). document governs data processing activity EBMT centre thus prerequisite specific participate CAR-T Data Collection Initiative. JCA signed centres, including participate CAR-T Data Collection Initiative. centre reimbursed? centre ha agreed participate Data Collection Initiative ha signed relevant contracts, centre reimbursed patient treated commercial CAR-T therapy product (re-)consent allow sharing data marketing authorisation holder health authority per stipulation Product-Specific Agreement. reimbursed patient treated marketing approval date post-marketing setting good quality data entered shared MAHs. specific detail inclusion period payment schedule provided Product-Specific Agreement. addition Agreements, EBMT inform site indication contracted pharma company get paid patients. new indication contracted pharma company EBMT inform site accordingly. summary: Kymriah mean inclusion target 2500 patient globally ha reached (competitive enrollment). 24 April 2023, inclusion wa closed product. patient included date reimbursed. marketing approval date Kymriah 23-Aug-2018 contracted indication were: pediatric young adult patient 25 year age B-cell acute lymphoblastic leukemia (ALL) refractory, relapse post-transplant second later relapse; treatment adult patient relapsed refractory (r/r) diffuse large B-cell lymphoma (DLBCL). Yescarta inclusion wa closed 31 December 2023. marketing approval date Yescarta 23-Aug-2018 contracted indication were: adult patient relapsed refractory diffuse large B-cell lymphoma (DLBCL) primary mediastinal large B-cell lymphoma (PMBCL). Abecma mean inclusion target 300 patient Europe ha reached (competitive enrollment). marketing approval date Abecma 18-Aug-2021 currently contracted indication are: adult patient multiple myeloma. Breyanzi mean inclusion target 200 patient Europe ha reached (competitive enrollment). marketing approval date Breyanzi 04-Apr-2022 currently contracted indication are: adult patient relapsed refractory (R/R) diffuse large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma (PMBCL), follicular lymphoma grade 3B (FL3B). Tecartus mean patient treated 18 Jan 2028, unless inclusion period closed earlier per EBMT notification. marketing approval date Tecartus 14-Dec-2022 currently contracted indication are: adult patient relapsed refractory (R/R) mantle cell lymphoma (MCL). product and/or additional indication expected follow near future. Find country. Find contact. EBMT ha appointed lead study coordinator lead investigator country. Please refer list identify contact person country. Country Lead EBMT Country lead PI Austria Guus Rijs Philipp Wohlfarth, MD, PhD; Medical University Vienna, Vienna Belgium Guus Rijs Sbastien Anguille, MD, PhD; Antwerp University Hospital/University Antwerp, Antwerp Croatia Paul Bosman Prof. Igor Aurer - University Hospital Center Rebro Czech Republic Paul Bosman Frantisek Folber, MD, PhD - Department Internal Medicine, Hematology Oncology, University Hospital Brno Denmark Guus Rijs Soeren Lykke Petersen, Consultant, MD, D. Msc. - Copenhagen University Hospital (Rigshospitalet) Estonia Jessica Lemaitre Finland Dilyana Georgieva Dr. Mervi Taskinen MD, PhD - University Helsinki, Helsinki France Jessica Lemaitre Pr Stphanie Nguyen -Universite Paris IV, Hopital la Piti-Salptrire, Paris Germany George Haroon Prof. Dr. med. Nicolaus Krger - University Hospital Eppendorf, Hamburg Greece Dilyana Georgieva Israel Paul Bosman Prof. Avichai Shimoni - Chaim Sheba Medical Center Italy Paul Bosman Dr. Annalisa Ruggeri MD, PhD - Ospedale San Raffaele s.r.l Netherlands Guus Rijs Dr. Pim Mutsaers van het Erasmus Medical Center, Rotterdam Norway Dilyana Georgieva Tobias Gedde-Dahl d.y. MD PhD - Oslo University HospitalRikshospitalet, Oslo Poland Paul Bosman Prof. Krzysztof Kalwak - Cape Hope, Wroclaw Portugal Jessica Lemaitre Slovenia Paul Bosman Dr. Matjaz Sever MD, PhD - University Medical Center Ljubljana Spain Paul Bosman Dr. Anna Sureda MD, PhD- ICO- Hospital Duran Reynals, Barcelona Sweden Dilyana Georgieva Prof. Dr. Stephan Mielke - Karolinska University Hospital, Stockholm Switzerland Jessica Lemaitre Prof. Dr. med. Caroline Arber Barth - universit de Lausanne,Centre hospitalier universitaire vaudois, Lausanne United Kingdom Dilyana Georgieva Dr. Sara Ghorashian, Great Ormond Street Hospital, London Contact u country listed Reporting Centres' testimonial CAR T-cell treated patient registered EBMT Registry EBMT Non-Profit Organisation EBMT non-profit organization supporting transplant cellular therapy community. line Mission, Vision Values, resource used improve life patient blood-related disorders. EBMT ha created level financial reserve able guarantee independence neutrality regarding scientific educational decision political economic interest.All income EBMT re-invested support community scientific, registry, accreditation educational activities. Recent activity output CAR include: International Training Course, GoCARTConsortium, EBMT-JACIE/EHACAR Guidelines, EBMT-EHA CAR Handbook CAR Data Registry amongst others. information EBMT's involvement PAS Studies please visit FAQs page. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Data Protection & Privacy EBMT Registry collect data research development new improved transplant, cell therapy immunosuppression procedures, improve quality procedure accreditation treatment units. EBMT strongly committed protecting privacy personal data maintain patients, donors, member employees. EBMT ensures personal data responsibility processed according EU General Data Protection Regulation (GDPR). data stored electronic database located European country protected safeguard ensure security, including compliance ISO27001 certification. data accessible EBMT employee appropriately authorised non-EBMT party National Registries, following stringent access control policy. Patient Privacy Statement webpagedetails personal data EBMT collect patients, collected stored purpose used. also information contact registry right individual data subjects. wa generated response new legislation, General Data Protection Regulation (Regulation (EU) 2016/679, hereafter GDPR). Privacy Policy webpage detail personal data EBMT collect members, collected stored purpose used. also information contact Registry right individual data subjects. wa generated response new legislation, General Data Protection Regulation (Regulation (EU) 2016/679, hereafter GDPR). Data Use Processing Policy Policy regulates management Personal Data relating patient reported EBMT Registry provides rule procedure apply department individual within EBMT, aimed ensuring Patient Personal Data processed protected properly country region accordance European General Data Protection Regulation (GDPR). Joint Controllership Agreement Centers full EBMT Membership EBMT strongly committed protecting privacy personal data obtain frompatients, member employees. context, EBMT ha developed Joint Controllership agreement Centers full EBMT membership describes responsibility concerning data protection data reported EBMT. time, agreement includes requirement established General Data Protection Regulation (EU 2016/679) (GDPR) concerning data processing controllership obligation EBMT member EBMT. documenthas produced EBMT GDPR working group, revised endorsed EBMT legal advisor compliance GDPR, finally approved EBMT Executive Committee. great importance EBMT member report data EBMT Registry sign document return EBMT. comment question EBMT process personal data, please send Joint Controllership Agreement Data reporting SFGM-TC EBMT EBMT encourages use Joint Controllership Agreement centre wish report EBMT SFGM-TC. great importance institutional representative EBMT/SFGMTC centre member, report data EBMT SFGM-TC Registries, sign document return document ha adapted French speaking SFGM-TC centre located outside France: Belgium, Switzerland, Lebanon Algeria. Data Confidentiality confidentiality patient data stored Registry paramount importance EBMT procedure place ensure data transferred stored highest possible level security. addition above, transfer storage confidential patient data must abide General Data Protection Regulation (Regulation (EU) 2016/679, hereafter GDPR). EBMT registered Dutch foundation, Dutch law applies EBMT, abide implementation European Union (EU) GDPR regulating personal data handled, Dutch application law. law regulating transfer data within EU doe cover country outside EU/EEA (European Economic Area), EBMT must ensure centre lying outside zone agree conform EU law stated above. law requires patient consent data transferred EBMT. addition, centre intends forward data, either directly EBMT, country located outside EU/EEA, must ensure explicitly stated patient consent form. Please see example consent form link below. centre responsibility ensure patient ha consented data forwarded EBMT. EBMT Registry Conditions Use Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Patient Donor Informed Consent Centres download fill Informed Consent Forms appropriate language patient donors, law requires patient donor consent data transferred EBMT. EBMT shall provide Informed Consent Forms participating site used data reporting EBMT. reporting centre shall responsible ensuring Informed Consent Forms compliance applicable law meet minimum requirement indicated Informed Consent template web page. centre exempt obtaining patientand donor consent submitting data EBMT. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Data Collection EBMT request member centre patient undergoing HCT, treatment aplastic anaemia, type cellular therapy registered EBMT Registry. EBMT Registry Data Collection Forms aid collection data required submitted EBMT Registry. Centres responsible ensuring patient donor consent data transferred EBMT, prior collecting data submission EBMT. Informed consent template instruction obtaining informed consent found Informed Consent page. Patient Registry Data Collection Forms order collect data, EBMT us set Data Collection Forms (DCFs). Data Collection Forms referred core dataset. minimum essential data must provided EBMT Member centre consenting patients. form organised corresponding event type EBMT Registry. Completion guideline available every Data Collection Form. introduction document completion guideline found Patient Registration find Data Collection Form Completion Guidelinefor new patient registrations, diagnosis treatment types. Document Name DCF Completion Guideline Patient Registration Diagnosis find Data Collections Forms Completion Guidelines per diagnosis. Document Name DCF Completion Guideline Acute Leukaemias Autoimmune Disorders Bone Marrow Failure Syndromes (BMF) inc. Aplastic Anaemia (AA) Chronic Leukaemias Combined Myelodysplastic Syndrome / Myeloproliferative Neoplasm (MDS/MPN) Haemoglobinopathies Inborn Errors Lymphomas Myelodysplastic Syndromes (MDS) Myeloproliferative Neoplasms (MPN) Indication Diagnosis Non-indication Diagnosis Plasma Cell Disorders (PCD) inc. Multiple Myeloma (MM) Solid Tumours Treatment find Data Collections Forms Completion Guidelines per treatment, including cellular therapy immunosuppressive treatments. Document Name DCF Completion Guideline Disease Status HCT/CT/IST Allogeneic HCT Autologous HCT Cellular Therapy Immunosuppressive Treatment (IST) Follow-up find Data Collections Forms Completion Guidelines registering Follow-ups per treatment, including cellular therapy immunosuppressive treatments. Document Name Timepoint DCF Completion Guideline HCT (both Autologous &Allogeneic) Day 100 HCT (both Autologous &Allogeneic) Annual/Unscheduled Cellular Therapy Day 100, 6 month &Annual/Unscheduled Immunosuppressive Treatment (IST) Day 100 Immunosuppressive Treatment (IST) Annual/Unscheduled Anonymous Events find Data Collection Form Completion Guideline registering non-consenting patients, per Centre's requirements. Document Name DCF Completion Guideline Anonymous Event Donor Outcome Registry Data Collection Forms Donor Outcome Registry Data Collection Forms find Data Collections Forms Completion Guidelines registering donor information Donor Outcome Registry. Document Name DCF Completion Guideline Donor Registration Donation Procedure Day 30 Follow-up Long-term Follow-up Death Reporting Manuals Reference Documents Document Download EBMT Registry User Manual Data Editors Data Viewers Introduction EBMT Registry Completion Guidelines List Chemotherapy Drugs, Agents Regimens List disease classification Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Data Submission EBMT request member centre patient undergoing HCT, treatment aplastic anaemia, type cellular therapy registered EBMT Registry. EBMT Registry Data Collection Forms aid collection data required submitted EBMT Registry. Centres responsible ensuring patient donor consent data transferred EBMT, prior collecting submitting data EBMT. Informed consent template instruction obtaining informed consent found Informed Consent page. request access EBMT Registry Data Editor Access Data Editor access allows user view, add, edit export data within context. user also see answer data queries. Users successfully complete required e-learning training obtain certification access EBMT Registry.Training use EBMT Registry arranged automatically EBMT person request access EBMT Registry. request Data Editor access submit data EBMT Registry must made completing fully correctly form below. completed form must emailed EBMT Registry Conditions Use found below. Data Viewer Access Data Viewer access allows user view export already submitted data within context. Users successfully complete required e-learning training obtain certification access EBMT Registry.Training use EBMT Registry arranged automatically EBMT person request access EBMT Registry. request Data Viewer access EBMT Registry must made completing fully correctly form below. completed form must emailed EBMT Registry Conditions Use found below. Access patient given prior treatment another centre data pertaining one patient must submitted patient record, even patient ha different treatment different centres. request access patient ha given prior treatment another centre must made completing fully correctly form below. completed form must emailed National Registries small number National Registries submit data EBMT Registry behalf centres. information available Data Sharing page. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Data Retrieval Page construction. Centres liberty run report data access to, per requirement needs. Centres encouraged run report themselves. Reports run user Data Editor Data Viewer access. Centres also request specific reports/exports (on data data own) run EBMT Registry staff. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Data Sharing EBMT share EBMT Registry data number companies, study groups, society organisation data submission data retrieval/research purposes, upon agreement line GDPR requirements. Data sharing data submission purpose spirit facilitating data registration centres, EBMT enter data sharing agreement organisation centre collaborate with, willing submit data EBMT behalf centres. agreement also allow organisation access data already submitted centre EBMT, provided centre made request. end result centre need submit data once, still fulfil data provision commitment partners. National Registries type organisation EBMT ha sharing Registry infrastructure many year special partnership ha fruitful all. National Registries independent EBMT access data centre respective country jurisdiction. centre either listed member National Registry requested explicitly EBMT share data National Registry. National Registries actively collaborate EBMT Registry data collection training Data Managers. small number National Registries enter data behalf centres. Please contact National Registry require information activities. Another type data sharing sharing EBMT Registry patient record centre patient treatments. information found section 'Access patient given prior treatment another centre'. see country National Registries EBMT actively collaborating. Austria Belgium Czech Republic France Germany Italy Netherlands Spain Switzerland UK Data sharing data retrieval/research purpose procedure place study groups/societies/organisations wish access multiple centre data EBMT Registry research purposes. Data Sharing service available centre member EBMT, wish share data research purposes. currently service free, EBMT reserve right charge study groups/societies/organisations service future. Centres charged service. Data sharing research purpose time-limited subject explicit request approval centre PI well subject approval EBMT. Please contact Registry Helpdesk request data sharing. appropriate request form forwarded you, depending type data sharing requested. Eurocord Centres request EBMT share data patient received cord blood HCT EuroCord. information found document below. Centres want share data EuroCord request completing fully correctly form below. completed form must emailed Stem Cell Transplant Immune Deficiencies Europe (SCETIDE) Centres request EBMT share data patient undergone HCT procedure primary immune deficiency FELH SCETIDE. Centres want share data SCETIDE request completing fully correctly form below. completed form must emailed Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Data Quality Page construction. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Registry Education & Training page directs training educational material made available EBMT Registry staff. question regarding training education provided EBMT Registry, please contact Registry Helpdesk on. Training use new EBMT Registry mandatory completed EBMT e-learning platform. training fully virtual, weekly Q&A session organised first week September 2023. Training use EBMT Registry arranged automatically EBMT person request access EBMT Registry. Instructions request access EBMT Registry found Data Submission page. Instructions access e-learning platform complete training use EBMT Registry sent individual uponreceiptof relevant EBMT Registry User Account Request form, detailed Data Submission page. Training Materials Data Collection Forms Completion Guidelines found Data Collection page. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Transplant Activity Survey Since 1990, EBMT ha carried annual Transplant Activity Survey prospectively collect number patient treated haematopoietic stem cell transplant (HSCT) according indication, donor type stem cell source. clinical unit perform type stem cell transplant participate survey whether member EBMT not. Transplant Activity Survey ha become tool assessing real picture HSCT Europe: exposing trends, illustrating current status providing essential data counselling planning. structure, standardised many years, excellent commitment participating team make possible observe change time evaluate factor associated changes. Activity Survey relevant individual transplant teams, national organisations, health care agency industry well patients. transplant team strongly encouraged join survey. & submit survey data Survey data request sent centre December year surveyed collected first half following year. 2023 survey open, deadline submission 2023 data 1 April, 2024. data captured via on-line survey(link sent centre individually EBMT Activity Survey Team), whereby transplanting team report entire annual activity indication, donor type stem cell source. allows reporting first allografts, first autograft (rows 1-32 sum row 33) additional transplant retransplants performed due disease progression, engraftment failure part planned multiple transplant protocol (row 34). Row 35 (all transplants) sum row 33 + row 34. Paediatric transplant activity (<18 year transplant) reported main table (row 1-32) indication, donor type stem cell source additionally total number row 36. Entering total number paediatric patient additionally row 36, enables u perform separate analysis paediatric adult data. total number non-myeloablative (including RIC) allogeneic transplants, either first non-first, reported row 37. number patient receiving un-manipulated donor lymphocyte infusion (DLI) 2023 reported row 38. Please enter data field according main reason giving DLI therapy. Please report number patient number infusions. Number patient receiving Immunosuppressive Treatments (IST) Bone Marrow Failure Syndromes (acquired congenital) 2023 reported row 39. Please enter number patient treated IST Aplastic Anaemia (AA) Bone Marrow Failure Syndromes separately. Table 2 dedicated reporting non HSCT cell therapies. Report number patient receiving cell therapy using manipulated selected cell centre 2023 indication donor type row 1-9. Report number patient number infusions: E.g., patient three NK infusion counted one patient. Cell therapy reported within outside context HSCT. Please also report CAR-T patient treated clinical trials, survey doe affect confidentiality issue provides overview many therapy performed Europe year. help reporting, please read Activity survey manual Guidelines contact us. Please submit data using on-line survey. unable submit data via on-line survey please contact us. submit data either mail post: Download EBMT survey transplant activity 2023 excel document below. Complete relevant data fields. Name save file CIC number centre details. CIC number, name file name institution. Email form survey coordinator () return post to: EBMT Transplant Activity Survey Team Rijnsburgerweg 10 2333 AA Leiden, Netherlands Manual & Guideline complete Survey, please read 'Activity Survey Manual' 'Guidelines' below. Forms Survey available on-line excel pdf format below. completed manner indicated & Submit Survey Data section above. see results? Data recent survey year presented EBMT annual meeting available participating team sponsors. EBMT Member want access recent data, please contact Activity Survey Coordinator. External person organisation may also apply access survey data payment fee. Please provide detailed information data required intended use Activity Survey Coordinator, ass feasibility request passing EBMT approval costing. Please note data may published treated confidential. internal use may used publication without obtaining prior consent. Activity Survey data published peer reviewed publication Bone Marrow Transplantation year. full set slide prepared annually showing trend development years. selection slide available request. Individual analysis maybe requested EBMT Partners Excellenceand participating team upon justification use. EBMT Transplant Activity Survey Team Please contact u Marina Atlija Statistical Analyst/Pharma Dedicated Data Manager Amsterdam, Netherlands Iliana Kleovoulou Statistical Analyst/ Pharma Dedicated Data Manager Leiden , Netherlands Aleksandra Witaszek Junior Business Manager fundraising@ebmt.org Leiden, Netherlands Helen Baldomero Activity Survey Expert Basel, Switzerland Jakob R. Passweg Activity Survey Clinical Advisor Switzerland Transplant Activity Survey Publications List Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Archived ProMISe Castor Documents Data entry ProMISe Castor closed. document information purpose only, used data collection process. find new EBMT Registry Data Collection Forms Data Collection page. HSCT MED-A Forms download separate MED-A form diagnosis graft type below. Alternatively, download full version. MED-A Day 0 Diagnosis Graft type Diagnosis autograft allograft Acute Leukaemias - Acute Myeloid Leukaemia (AML) Acute Leukaemias - Precursor Lymphoid Neoplasms (PLN) Acute Leukaemias - acute leukaemia Autoimmune Diseases Bone Marrow Failure inc Aplastic Anaemia Haemoglobinopathy Chronic Leukaemias - Chronic Myeloid Leukaemia (CML) Chronic Leukaemias - Chronic Lymphocytic Leukaemia (CLL) Chronic Leukaemias - Prolymphocytic Leukaemia (PLL) / leukaemia Inherited Disorders Lymphomas - Hodgkins Lymphomas - B-cell Non Hodgkins (NHL) Lymphomas - T-cell Non Hodgkins (NHL) MDSs MPNs - Myelodysplastic Syndromes (MDS) MDSs MPNs - Combined Myelodysplastic / Myeloproliferative (MDS/MPN) MDSs MPNs - Myeloproliferative Neoplasms (MPN) Plasma Cell Disorders (PCD) inc Multiple Myeloma Solid Tumours MED-A Day 100 Follow Graft Type Document autograft allograft Day 100 Follow Additional MED-A Documents Document Download MED-A Forms Full Version Summary MED-A change (April 2016 onwards) HSCT MED-B Forms One two type-specific form (Allograft Autograft) must submitted transplant. Additionally, least one disease form must submitted transplant. Type-specific Forms Autograft Allograft Disease-specific Forms Acute Leukaemia Amyloidosis Bone Marrow Failure Syndromes inc Aplastic Anaemia CLL CML Haemoglobinopathy Inherited Disorders Juvenile Idiopathic Arthritis (JIA) Lymphoma MDS MDS/MPN (e.g. CMML, JMML) MPN Multiple Sclerosis Plasma Cell Disorders inc Multiple Myeloma Solid Tumours Systemic Lupus Erithematosus (SLE) Systemic Sclerosis Additional Forms Total Body Irradiation Clinical Manuals & Reference Documents Document Download MED-AB Forms Manual Cellular Therapy Manual Donor Outcome Manual MED-AB List Drug Names Synonyms Definitions Disease Status Response Disease (xls) Definitions Disease Status Response Disease NIH-defined GvHD IDWP - Definitions Infectious Diseases Complications SCT Castor Handbook Cellular Therapy Forms Manual Cellular Therapy Forms Document Download Cellular Therapy Pre-Infusion Registration Form Cellular Therapy Day 0 Form Cellular Therapy Day 100, 6M Annual Follow Form Donor Outcome Forms Document Download Donor Outcome Forms Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Research EBMT research aim knowledge base haematopoietic stem cell transplantation cell therapy ultimate goal improving patient care. EBMT coordinate scientific activity 11 Working Parties Nurses Group. Since 1974, use EBMT data statistical resource ha resulted hundred publication peer-reviewed scientific journals. EBMT Studies Learn EBMT's ongoing research haematopoietic stem cell transplantation find type study undertake submit proposals. EBMT Publications Members receive information co-operative study result EBMT research project access EBMT Registry Research Groups EBMT coordinate scientific activity 11 Working Parties, either disease-based transversal, EBMT Nurses' Research Group. Learn focus research carried group page below. Research Grants & fellowship EBMT offer grant fellowship research projects. Research News Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / EBMT Publications EBMT data statistical resource resulted 600 publication peer-reviewed scientific journal since 1974. addition, EBMT organisation publishes journal, Bone Marrow Transplantation, featuring high-quality, peer-reviewed original research review field haematopoietic cell transplantation. Download documentbelow read guideline requirement publication, visit BMT Journal website. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Area - -EBMT OrganizationResearchRegistry/Data ManagementNurses GroupEventsTraining/EducationAccreditationPatients & DonorsTransplant Activity Survey Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Year - -198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024 Disease - -All diseasesAcute Myeloid Leukaemia (AML)Chronic Myeloid Lymphoma (CML)Acute Lymphatic Leukaemia (ALL)Chronic Myeloid Leukaemia (CML)Chronic Lymphocytic Leukaemia (CLL)Myelodysplastic (MDS) MDS/MPNMyeloproliferative Neoplasm (MPN)Multiple Myeloma (MM) Plasma Cell Disorder (PCD)Hodgkins Disease (HD)Non-Hodgkins Lymphoma (NHL)Other myeloid lymphoid malignanciesSolid tumorsBone marrow failureAuto immune disordersInherited disordersOther non-malignant disordersComplications: GvHDComplications: infectiousComplications: non-infectiousCOVID-19 Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Year - -2015201620172018201920202021202220232024 Month - -JanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Area - -EBMT OrganizationResearchRegistry/Data ManagementNurses GroupEventsTraining/EducationAccreditationPatients & DonorsTransplant Activity Survey Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / EBMT Studies EBMT Working Groups, Nurses Group, GoCART coalition support Statistical Committee Study Offices, carry three type Studies: Non-interventional Prospective Retrospective Studies well Clinical Trials. EBMT Study Proposal Selection Process Policy EBMT CAR-T Studies Open Surveys Centre participation critical importance efficacy overall relevance Studies carried EBMT. reason, page dedicated New Studies open call participation surveys. accessing page learn new study whether centre eligible submit survey data included. Research Overview Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Study type - -- None -Clinical Trials Phase I-IIIClinical Trials Phase IVPost Authorization Safety (PAS) StudiesNon-interventional Prospective StudiesRetrospective StudiesSurveys Disease - -All diseasesAcute Myeloid Leukaemia (AML)Chronic Myeloid Lymphoma (CML)Acute Lymphatic Leukaemia (ALL)Chronic Myeloid Leukaemia (CML)Chronic Lymphocytic Leukaemia (CLL)Myelodysplastic (MDS) MDS/MPNMyeloproliferative Neoplasm (MPN)Multiple Myeloma (MM) Plasma Cell Disorder (PCD)Hodgkins Disease (HD)Non-Hodgkins Lymphoma (NHL)Other myeloid lymphoid malignanciesSolid tumorsBone marrow failureAuto immune disordersInherited disordersOther non-malignant disordersComplications: GvHDComplications: infectiousComplications: non-infectiousCOVID-19 Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Type transplant - -- None -AllogeneicAllogeneic - RelatedAllogeneic - UnrelatedAllogeneic - HaploidenticalAutologousDonor Leukocyte Infusion (DLI)CAR TGene TherapyCellular therapy (other DLI) Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Open Surveys following list represents Studies call participation currently open. Learn individual study below, click link find Working Party responsible study. Post-transplant haemorrhagic cystitis (HC) patient undergo allogeneic haematopoietic stem cell transplantation (HSCT) Group Infectious Diseases Working Party (IDWP) Haemorrhagic cystitis (HC) common complication haematopoietic stem cell transplantation (HSCT) referring bleeding bladder mucosa due urinary bladder inflammation. Early-onset HC ha associated bladder mucosal damage chemotherapy radiotherapy conditioning phase, late-onset HC peri-engraftment period increasingly associated BK polyoma virus infection. Even though significant development transplant practice last years, HC transplant patient ha investigated among EBMT centre last decade. Therefore, current study aim obtain information practice management, well incidence outcome, HC EBMT transplant patients. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Acute Leukaemia Working Party (ALWP) Acute Leukemia Working Party relies large registry based Paris. devoted promotion analysis primary secondary myeloid lymphatic acute leukemia aspect associated transplantation stem cell Autologous donor type including deplete replete Haploidentical transplant well cord blood transplantation, including prospective retrospective studies, education field. Learn ALWP last decades, study conducted ALWP member yielded significant amount scientific knowledge, creating basis continuously improving patient care. support different ALWP subcommittees' leader (F. Ciceri, J. Esteve, S. Giebel, NC. Gorin, F. Baron, B. Savani C. Schmid), data manager (E. Polge, A. Mailhol, M. Houhou, E. Penisson (part time)), help invited Post Doc fellows, (Eder S. (Austria), Lorentino F. (Italy) Sun Y. (China)), dedicated statistician, M. Labopin, ALWP member EBMT participating centres, study portfolio ALWP ha grown quickly, generated amazing number published manuscript communication major meeting EBMT, ASH, EHA ASBMT/CIBMTR Tandem meetings. huge scientific productivity ALWP past month good illustration success EBMT strategy. deeply believe capacity ALWP - support cooperation working party EBMT leadership - continue facing new challenge successfully. ALWP Team Fabio Ciceri Scientific Council chair Research Sciences portfolio ALWP Chair Congress Co-President Milan, Italy Eolia Brissot Secretary ALWP France Emmanuelle Polge ALWP, TCWP, GoCART Clinical Data Specialist Paris, France Irma Khvedelidze ALWP & LWP Study Coordinator Paris, France Mohamed Houhou ALWP Study Coordinator Paris, France Pascale Ambron ALWP, ADWP, TCWP DATA MANAGER Paris, France Diane Bacabac ALWP, PDWP Junior Data Manager Paris, France Aleksandra Gavrilina ALWP, LWP, PDWP Junior Data Manager Paris, France Myriam Labopin ALWP, ADWP Senior Biostatistician Paris, France Jacques-Emmanuel Galimard ALWP, PDWP, HWP, GoCART Biostatistician Statistical Committee Chair Registry Committee Paris, France Maud Ngoya ALWP, LWP, PDWP Biostatistician Paris, France EBMT Study Proposal Selection Process Policy News ALWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Subcommittees & Members Jordi Esteve Molecular Markers Subcommittee Spain Arnon Nagler honorary member ALWP CHAIR 2014-2018 ALWP Molecular Subcommittee Israel Sebastian Giebel Acute Lymphoid Leukaemia Subcommittee Poland Zinaida Peri TCWP Chair Acute Lymphoid Leukaemia Subcommittee Croatia Bipin Savani Conditioning Subcommittee United States Alexandros Spyridonidis Conditioning Subcommittee Greece Frdric Baron Cord Blood Subcommittee Belgium Christoph Schmid Immunotherapy Subcommittee Germany Norbert Claude Gorin Global Committee Chair, Chief Representative EBMT Shanghai Office AUTO-SCT graft composition subcommittee Honorary member Paris, France Francesco Lanza AUTO-SCT graft composition subcommittee Italy Roni Shouval Data mining Subcommittee Jurjen Versluis Data mining Subcommittee Netherlands Gesine Bug Post-transplant pharmacologic modulation subcommittee Germany Ali Bazarbachi LWP Chair Member Global Committee Post-transplant pharmacologic modulation subcommittee Beyrouth, Lebanon Jaime Sanz Caballer Alternative donor subcommittee Spain Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Severe Aplastic Anaemia Working Party (SAAWP) SAAWP report Aplastic Anaemia (AA) rare acquired inherited bone marrow failure disorders. SAAWP provides essential data outcome treatment large number patient obtained large registry like EBMT. also provides important clinical information needed help classify characterise disease data natural history disease late effect occur treatment. SAAWP hold Aplastic Anaemia (AA) database disease-specific database within EBMT. Data collected patient receiving transplant also form therapy, including immunosuppressive therapy. SAAWP Team Antonio Risitano SCIENTIFIC COUNCIL representative Registry portfolio SAAWP Chair Italy Austin Kulasekararaj SECRETARY SAAWP United Kingdom Kelly Hennessy SAAWP Nurse United Kingdom Brian Piepenbroek SAAWP STUDY COORDINATOR LEAD Nurses Group Study Coordinator Lead Leiden, Netherlands Joe Tuffnell CMWP & SAAWP Data Manager Leiden, Netherlands Simona Iacobelli CMWP & SAAWP Senior Biostatistician Rome, Italy Dirk-Jan Eikema CMWP & SAAWP Biostatistician Leiden, Netherlands EBMT Study Proposal Selection Process Policy News SAAWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Autoimmune Diseases Working Party (ADWP) ADWP dedicated promoting clinical activities, teaching translational research autologous/allogeneic HSCT together novel approach cellular therapy specific treatment severe Autoimmune Diseases (AD), specific challenge re-induce self-tolerance resetting immune system. ADs section EBMT Registry largest database kind worldwide. ADs recently facing unique developmental phase across EBMT centres. Autologous HSCT ha become integral standard-of-care part treatment algorithm multiple sclerosis (MS) systemic sclerosis (SSc). Recently, novel cellular therapy (ie CART cells, mesenchymal cells) successfully adopted ADs. multidisciplinary approach key field, ADWP ha strategic task interacting Autoimmune Diseases (AD) specialist respective scientific societies. ADWP Team Tobias Alexander ADWP Chair Germany Ariadna Domnech ADWP Nurse Spain Manuela Badoglio ADWP Study Coordinator Paris, France Pascale Ambron ALWP, ADWP, TCWP DATA MANAGER Paris, France Myriam Labopin ALWP, ADWP Senior Biostatistician Paris, France EBMT Study Proposal Selection Process Policy Events News ADWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Cellular Therapy & Immunobiology Working Party (CTIWP) mission Cellular Therapy & Immunobiology Working Party understand exploit biological, including immunological, event occurring upon haematopoietic stem cell transplantation large, implement modern cellular therapy based cell gene engineering approach improve transplantation outcomes. Learn CTIWP Cellular Therapy emerging medical science today facing unique developmental phase, well documented outstanding growing number clinical trials. exponential growth requires proper infrastructures, cell repositories, clinical registries, technical regulatory guideline appropriate cell manipulation validation innovative therapeutic approach multicentric clinical trials. CTIWP aim fostering cellular therapy Europe, continuous crosstalk basic science findings, transplant immunobiology observation implementation cellular manufacturing approach designed answer unmet medical needs. aim actively implement: Retrospective multicentric prospective transplant immunobiology study Retrospective multicentric prospective clinical trial cell/gene therapy map European Centers active cell manipulation cell therapy dedicated registry cellular product clinical trial cell cell-based gene therapy. aim pursued activity WP subcommittee active collaboration International European Societies Transplantation, Cell/Gene Therapy major investor field. CTIWP Team Annalisa Ruggeri SCIENTIFIC COUNCIL representative Education portfolio CTIWP Chair PRACTICE HARMONISATION COMMITTEE VICE-CHAIR Italy Florent Malard CTIWP SECRETARY Initiative Microbiota France Ruth Clout CTIWP Nurse United Kingdom Jrgen Kuball LRAC Chair Liaison European Medicines Agency, European Commission & Industry Netherlands Jorinde Hoogenboom CTIWP Study Coordinator Lead Leiden, Netherlands Jarl Mooyaart CTIWP & Nurses Group Biostatistician Leiden, Netherlands Jeroen Knippenberg IEWP & CTIWP Data Manager Leiden, Netherlands EBMT Study Proposal Selection Process Policy Events News CTIWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Subcommittees & Members Immunogenetics Katharina Fleishhauer Esteban Arrieta Bolanos Microbiota Florent Malard Giorgia Battipaglia Solid tumor Paolo Pedrazzoli Ulrike Koehl Liaison EBMT Nurses Group Ruth Clout Hematopoietic stem cell subcommittee Eurocord Annalisa Ruggeri Fernanda Volt Transplantation immunology Nicole Santoro Moniek de Witte, Federico Simonetta CART cell immunology Simona Pagliuca Ana Alarcon Immunotherapy pediatric AYA Francesca Del Bufalo Sara Gorashian Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Chronic Malignancies Working Party (CMWP) Chronic Malignancies Working Party promotes conduct educational activity clinical investigation role hematopoietic cell transplantation chronic malignancy chronic leukaemias, myelodysplastic syndromes, myeloproliferative plasma cell disorders. CMWP aim contribute improving outcome patient undergoing stem cell transplantation chronic hematologic malignancy following means: Performing high quality retrospective registry study Performing prospective clinical trial non-interventional study (NIS) Improving quality EBMT registry data Promoting scientific interaction organising educational course scientific meeting Collaborating national international transplant- disease-specific group Disseminating knowledge transplant non-transplant scientific communities, patient organisation lay public CMWP Team Donal McLornan Scientific Council co-chair Research Sciences portfolio CMWP Chair United Kingdom Joanna Drozd-Sokolowska Co-Secretary CMWP Poland Kavita Raj Co-Secretary CMWP United Kingdom Maaike de Ruijter CMWP Nurse Netherlands Linda Koster CMWP Study Coordinator Lead Clinical Programmer Registry Committee Leiden, Netherlands Laurien Baaij CMWP DATA MANAGER Leiden, Netherlands Joe Tuffnell CMWP & SAAWP Data Manager Leiden, Netherlands Simona Iacobelli CMWP & SAAWP Senior Biostatistician Rome, Italy Dirk-Jan Eikema CMWP & SAAWP Biostatistician Leiden, Netherlands Luuk Gras CMWP Biostatistician Leiden, Netherlands Structure CMWP consists five subcommittees: Myelodysplastic syndrome (MDS) including Chronic Myelomonocytic Leukaemia (CMML) Plasma Cell Disease (PCD) CART PCD Philadelphia-negative Myeloproliferative Neoplasms (Ph-neg MPN) Chronic Myeloid Leukaemia (CML) Chronic Lymphocytic Leukaemia (CLL) subcommittee chair one two vice-chairs. Vice-chairs act co-chairs directly responsible least two studies. (Chairs subcommittee allocate least two study vice-chair) chair CMWP appoints chair vice-chairs subcommittees. Subcommittee member served four year board may replaced provide opportunity interested WP members. goal current chair board reflect international range EBMT-affiliated centres. Membership Working Party membership open physician EBMT-affiliated Transplant Centres. Applicants elsewhere welcome apply join. final decision rest Chair Working Party. secretary maintains list members. member ha attended meeting two years, deemed left Working Party longer receive group email communication Secretary. EBMT Study Proposal Selection Process Policy News CMWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Inborn Errors Working Party (IEWP) IEWP dedicated improving outcome transplantation inborn error metabolism including severe congenital immunodeficiency metabolic diseases. IEWP aim exchange idea transplant data; international collaborative retrospective study look outcome transplant conditions; development transplant guideline education transplant physician worldwide; development use common registry document analyze result treatment. IEWP Team Bndicte Neven IEWP Chair France Michael Albert Secretary IEWP Germany Marina Ben Izhak IEWP Nurse Israel Tiarlan Sirait IEWP Study Coordinator Lead Leiden, Netherlands Patrick Gilbert IEWP Statistician Leiden, Netherlands Jeroen Knippenberg IEWP & CTIWP Data Manager Leiden, Netherlands EBMT Study Proposal Selection Process Policy News IEWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Infectious Diseases Working Party (IDWP) IDWP aim promote conduct educational activity clinical investigation topic concerning diagnosis, prophylaxis management infectious complication following HSCT. mission IDWP share experience develop cooperative study increase education field diagnosis, prophylaxis treatment infectious complication HSCT patients. IDWP Members continue scientific educational activity field of: bacterial infections, viral infections, fungal infection including pneumocystis jiroveci infections, parasitic infections, vaccinations, protective environment guideline area transplant infectious diseases. IDWP Team Dina Averbuch IDWP Chair Israel Nina Knelange IDWP Study Coordinator Lead Leiden, Netherlands Lotus Wendel IDWP STUDY COORDINATOR Leiden, Netherlands Inge Verheggen IDWP Data manager Leiden, Netherlands Gloria Tridello IDWP Biostatistician Verona, Italy Juana Schwartz Mota IDWP Data Entry Clerk Pamplona, Spain EBMT Study Proposal Selection Process Policy ECIL IDWP one four participating body , along withthe EORTC Infectious Diseases Group, Supportive Care Group ELN, Immunocompromised Host Society. News IDWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Lymphoma Working Party (LWP) LWP devoted advancing research promoting education regarding role stem cell transplantation management patient lymphoid malignancies. LWP composed panel expert Hodgkin lymphoma non Hodgkin lymphoma, including diffuse large B-cell lymphoma, T-cell lymphomas, mantle cell lymphoma, follicular lymphoma Waldenstrm macroglobulinemia. panel supported excellent help Herv Finel Irma Khvedelidze, Study Coordinators, Ariane Boumendil, Statistician. joint effort team ha resulted active portfolio ongoing study numerous presentation international meeting publication peer-reviewed journals. includes retrospective prospective studies, well guideline position papers. Follow u Twitter @LymphomaWP_EBMT Learn LWP management patient lymphoma ha changed extraordinarily last 10-15 years. advent rituximab ha resulted significant improvement outcome several type lymphoma. recently, plethora new agent strong biological rational becoming available treatment patient lymphoid malignancies. parallel, advance haematopoietic cell transplantation technology, reduced toxicity conditioning, haplo-transplantation, CAR cell therapy improved outcome widened applicability stem cell transplantation lymphoma, particularly elderly patient without matched donor. challenge continuously define appropriate place stem cell transplant therapeutic algorithm patient lymphoma concert novel pharmacological options. largest database patient undergone stem cell transplant lymphoma combined expertise transplant community, LWP privileged position contribute aim. LWP Team Ali Bazarbachi LWP Chair Member Global Committee Post-transplant pharmacologic modulation subcommittee Beyrouth, Lebanon Anna Ossami Saidy Secretary LWP Germany Jenni Davies LWP Nurse United Kingdom Herv Finel LWP Study Coordinator Paris, France Irma Khvedelidze ALWP & LWP Study Coordinator Paris, France Aleksandra Gavrilina ALWP, LWP, PDWP Junior Data Manager Paris, France Maud Ngoya ALWP, LWP, PDWP Biostatistician Paris, France EBMT Study Proposal Selection Process Policy Events News LWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Subcommittees & Members Sascha Dietrich Member Germany Peter Dreger Member Germany Olivier Hermine Member France Chara Kyriakou Member United Kingdom Norbert Schmitz Member Germany Harry Schouten Member hematologie@mumc.nl Netherlands Anna Sureda EBMT President Congress Co-President Barcelona, Spain Alina Tanase Member Romania Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Paediatric Diseases Working Party (PDWP) PDWP aim support research education improve availability, safety, efficacy HSCT cellular therapeutic child adolescents; engage promote active co-operation EBMT working party treating child adolescent effort meet total need full spectrum paediatric HSCT patients; initiate perform prospective, collaborative, GCP-conform study malignant non malignant paediatric diseases; develop close collaboration expert Leukaemia/Chemotherapy national frontline study order define optimal timing HSCT incorporate transplant recommendation disease-specific protocols; implement new regulation paediatric medicine EMEA; offer physician nursing staff small new centre practical training fellowship experienced transplantation unit European Collaborative Paediatric HSCT network; develop established Paediatric Standards within Accreditation Process JACIE guarantee maintain high quality patient care experience. PDWP Team Krzysztof Kalwak PDWP Chair Poland Katharina Kleinschmidt SECRETARY PDWP Germany Ida Bremer Ophorst PDWP NURSE CHAIRPERSON NG PAEDIATRIC COMMITTEE Netherlands Arnaud Dalissier PDWP, HWP Study Coordinator Paris, France Aleksandra Gavrilina ALWP, LWP, PDWP Junior Data Manager Paris, France Diane Bacabac ALWP, PDWP Junior Data Manager Paris, France Jacques-Emmanuel Galimard ALWP, PDWP, HWP, GoCART Biostatistician Statistical Committee Chair Registry Committee Paris, France Maud Ngoya ALWP, LWP, PDWP Biostatistician Paris, France Mouad Abouqateb PDWP, TCWP Biostatistician Paris, France Subcommittees & Members PDWP Organigram EBMT Study Proposal Selection Process Policy Events News PDWP Subcommittee Goals Action Plans PDWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Transplant Complications Working Party (TCWP) aim Transplant Complications Working Party conduct research well provide education expertise subject non-infectious complication hematopoietic cell transplantation. major field interest TCWP are: Early complication e.g. graft failure, VOD/SOS, transplant-associated microangiopathy (TAM), endothelial syndromes, impact co-morbidities, toxicity conditioning regimen supportive care; Acute chronic graft versus host disease aspect risk factor diagnosis treatment; Late effect e.g. infertility, sexual dysfunction, secondary cancers, organ-specific late complications, quality life. TCWP transversal Working Party, covering complication occurring transplantation indications. Therefore, performance strictly related collaboration disease-specific working parties, study directly dedicated non-infectious complication performed either close collaboration TCWP. TCWP Team Zinaida Peri TCWP Chair Acute Lymphoid Leukaemia Subcommittee Croatia Ivan Moiseev TCWP Secretary EARLY COMPLICATIONS REGIMEN-RELATED TOXICITIES SUBCOMMITTEE CHAIR TCWP Russian Federation Sophie Van Lancker TCWP Nurse Belgium Emmanuelle Polge ALWP, TCWP, GoCART Clinical Data Specialist Paris, France William Boreland TCWP Study Coordinator Paris, France Pascale Ambron ALWP, ADWP, TCWP DATA MANAGER Paris, France Christophe Peczynski TCWP, GoCART Senior Biostatistician Paris, France Mouad Abouqateb PDWP, TCWP Biostatistician Paris, France EBMT Study Proposal Selection Process Policy Events News TCWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Subcommittees & Members Olaf Penack Graft-versus-host disease Subcommittee Chair TCWP Germany Hlne Schoemans Survivorship Subcommittee Chair TCWP Patient Engagement Taskforce Coordinator Belgium @Hschoemans Sophie Van Lancker TCWP Nurse Belgium Alberto Mussetti ARTIFICIAL INTELLIGENCE SUBCOMMITTEE CHAIR TCWP Spain Charlotte Graham CAR-T COMPLICATIONS SUBCOMMITTEE CHAIR TCWP United Kingdom William Boreland TCWP Study Coordinator Paris, France Christophe Peczynski TCWP, GoCART Senior Biostatistician Paris, France Related Organisations Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Haemoglobinopathies Working Party (HWP) new era hemoglobinopathy treatment began 40 year ago allogeneic haematopoietic stem cell transplantation provided first cure genetic conditions. 10,000 patient received transplant since currently, gene therapy beginning new era. result, patient suffering hemoglobinopathy several therapeutic option choose from. new Hemoglobinopathies Working Party (HWP), potential redefine transplant journey modality compare different option order choose best option patients. main objective HWP to: Promote scientific activity involving investigator around world, especially area disease prevalent Collaborate closely WPs Thalassemia Sickle Cell Disease specialist association Improve data collection quality view long-term clinical benefit HWP Team Emanuele Angelucci HWP CHAIR Italy Josu de la Fuente HWP SECRETARY United Kingdom Sandrine Bremathas HWP NURSE United Kingdom Arnaud Dalissier PDWP, HWP Study Coordinator Paris, France Jacques-Emmanuel Galimard ALWP, PDWP, HWP, GoCART Biostatistician Statistical Committee Chair Registry Committee Paris, France EBMT Study Proposal Selection Process Policy News HWP Publications List Guidelines, Consensus Statements, Position Papers Studies Related document Subcommittees & Members Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / Biostatistics EBMT Statistical expertise support EBMT provided group Statisticians Statistical Committee. statistician employed either Paris Leiden Study Units. Statistical Committeeis group scientist keen interest biostatistics stem-cell transplant, regardless employment EBMT. task Statistical Committeeis safeguard quality methodological activity education. Paris Leiden Study Units cooperate exchange methodological knowledge, work together Statistical Committee, disseminate knowledge throughout EBMT. Support EBMT Studies development clinical research, statistician responsible adherence study methodological standard sound scientific research. achieved analyzing data proper statistical technique importantly contributing planning study, interpretation communication results, acting scientific fellow Principal Investigator. EBMT Studies conducted within Working Parties Paris Leiden EBMT Data Offices. Proposals evaluated refined WP Chair WP members, collaboration data manager statistician statistical analysis approved study done WP statistician according availability resource WP priorities. cases, WP statistician might cooperate external statistician advisor / reviewer. Planning Data Preparation Statistical Analysis Communication & Publication Statistical Tools & Software Guidelines, Consensus Statements & Position Papers Related Documents Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Annual Meeting & Educational Events Annual Meeting EBMT important annual event research education field blood marrow transplantation cellular therapyin Europe. attracts 5,500 participants, including international experts, scientists, physicians, nurses, statisticians, clinical research technicians, patient processing laboratory personnel. Besides Annual Meeting, EBMT Working Parties, Committees Groups put specialised educational event throughout calendar year, offering in-depth content sub-specialities within BMT. Read learn participate. Future Annual Meeting Dates 51st Annual Meeting EBMT Date: 30 March - 2 April 2025 Florence, Italy 52nd Annual Meeting EBMT Date: 22-25 March 2026 Venue: announced 53rd Annual Meeting EBMT Date: 11-14 April 2027 Venue: announced Upcoming Educational Events EBMT offer range educational event varying duration subject matter member interested parties. vary four-day residential course specialist session Annual Meeting EBMT. Members EBMT attend Annual Meeting Educational Events discounted rate Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / Past Annual Meetings EBMT Click following link access information resource past EBMT Annual Meetings. Celebrating 50 Years Community 50th Annual Meeting EBMT taking place wonderfulcity Glasgow 14-17 April 2024. Come celebrate remarkable achievement European international transplant community past 50 years. Sign today showcase research front thousands. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Country - -Afghanistanland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius SabaBosnia HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosDemocratic Republic CongoCongoCook IslandsCosta RicaCte d'IvoireCroatiaCubaCuraaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiNorth KoreaSouth KoreaKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNiger (the)NigeriaNiueNorfolk IslandNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRunionRomaniaRussian FederationRwandaSaint BarthlemySaint HelenaSaint Kitts NevisSaint LuciaSaint MartinSaint Pierre MiquelonSaint Vincent GrenadinesSamoaSan MarinoSao Tome PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad TobagoTunisiaTurkeyTurkmenistanTurks Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin IslandsVirgin Islands (U.S.)Wallis FutunaWestern Sahara*YemenZambiaZimbabwe Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Diseases - -All diseasesAcute Myeloid Leukaemia (AML)Chronic Myeloid Lymphoma (CML)Acute Lymphatic Leukaemia (ALL)Chronic Myeloid Leukaemia (CML)Chronic Lymphocytic Leukaemia (CLL)Myelodysplastic (MDS) MDS/MPNMyeloproliferative Neoplasm (MPN)Multiple Myeloma (MM) Plasma Cell Disorder (PCD)Hodgkins Disease (HD)Non-Hodgkins Lymphoma (NHL)Other myeloid lymphoid malignanciesSolid tumorsBone marrow failureAuto immune disordersInherited disordersOther non-malignant disordersComplications: GvHDComplications: infectiousComplications: non-infectiousCOVID-19 Area category - -EBMT OrganizationResearchRegistry/Data ManagementNurses GroupEventsTraining/EducationAccreditationPatients & DonorsTransplant Activity Survey Event type - -EBMT Annual MeetingBusiness MeetingEducational MeetingTraining Course Date start Date end Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Country - -Afghanistanland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius SabaBosnia HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosDemocratic Republic CongoCongoCook IslandsCosta RicaCte d'IvoireCroatiaCubaCuraaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiNorth KoreaSouth KoreaKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNiger (the)NigeriaNiueNorfolk IslandNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRunionRomaniaRussian FederationRwandaSaint BarthlemySaint HelenaSaint Kitts NevisSaint LuciaSaint MartinSaint Pierre MiquelonSaint Vincent GrenadinesSamoaSan MarinoSao Tome PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad TobagoTunisiaTurkeyTurkmenistanTurks Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin IslandsVirgin Islands (U.S.)Wallis FutunaWestern Sahara*YemenZambiaZimbabwe Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Diseases - -All diseasesAcute Myeloid Leukaemia (AML)Chronic Myeloid Lymphoma (CML)Acute Lymphatic Leukaemia (ALL)Chronic Myeloid Leukaemia (CML)Chronic Lymphocytic Leukaemia (CLL)Myelodysplastic (MDS) MDS/MPNMyeloproliferative Neoplasm (MPN)Multiple Myeloma (MM) Plasma Cell Disorder (PCD)Hodgkins Disease (HD)Non-Hodgkins Lymphoma (NHL)Other myeloid lymphoid malignanciesSolid tumorsBone marrow failureAuto immune disordersInherited disordersOther non-malignant disordersComplications: GvHDComplications: infectiousComplications: non-infectiousCOVID-19 Area category - -EBMT OrganizationResearchRegistry/Data ManagementNurses GroupEventsTraining/EducationAccreditationPatients & DonorsTransplant Activity Survey Event type - -EBMT Annual MeetingBusiness MeetingEducational MeetingTraining Course Date start Date end Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / Related Events & Partners EBMT part larger haematology cancer research community work conjunction partner across globeto advance fight cancer disease blood. Manyother organisation working field also offer high-quality educational event throughout year. Related Events GvHGvL Meeting 2024 Regensburg, Germany 13-15 March 2024 GI-Oncology 2024 20th Interdisciplinary Update Wiesbaden, Germany 15 June 2024 57th Annual Meeting German Society Transfusion Medicine Immunohaematology (DGTI) & 31st Annual Meeting German Society Immunogenetics (DGI) Dsseldorf, Germany 11-13 September 2024 22nd Meeting European Association Haematopathology Croatia, Dubrovnik 21-26 September 2024 SIOP 2024 - 56th Congress International Society Paediatric Oncology Honolulu, Hawaii, USA 17-20 October, 2024 ESH-EBMT-EHA 3rd Translational Research Conference onBone Marrow Failure Leukaemia Predisposition Syndromes Paris, France 15-17 November 2024 Media Partners touchONCOLOGYandtouchHAEMATOLOGYare proud forefront on-demand virtual formats, pushing boundary online medical education. Learn fromtouchONCOLOGY&touchHAEMATOLOGYand CME-accredited independent learning activity Watch highlight coverage leading international ONCOLOGY HAEMATOLOGY congress Read latest article peer-reviewed therapy journal unique expert insight developed fortouchONCOLOGYandtouchHAEMATOLOGY Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Education EBMT Education EBMT Educational Programme EBMT Educational Programme play central role advancing knowledge, promoting best practices, fostering professional development field Hematopoietic Cell Transplantation (HCT) Cellular Therapies (CT) through: 1. Standardising education: EBMT educational programme assumes pivotal role developing standardising educational content HCT CT. establishing consistent high-quality educational materials, programme actively contributes providing healthcare professional across diverse region consistent level education. 2. Keeping pace advances: field HCT CT dynamic, continuous advancement research, technology, clinical practices. EBMT educational programme help learner stay abreast development regularly updating educational material providing healthcare professional latest knowledge. 3. Global collaboration: EBMT educational programme facilitates collaboration bringing together expert diverse background contribute educational initiatives. international perspective enriches educational content broad range experience approaches, fostering global community healthcare professionals. 4. Promoting best practice standard field: disseminating guidelines, protocols, best practice recommendation ensure EBMT community ha access updated educational materials. 5. Training future generations: essential aspect EBMT educational programme contribute ongoing education next generation healthcare professional HCT CT. 6. Addressing knowledge gaps: EBMT committed identifying area knowledge gap emerging challenge may exist HCT CT address targeted educational initiatives. 7. Continuous learning culture: EBMT contributes fostering culture continuous learning within HCT CT fields. providing ongoing educational opportunities, EBMT encourages healthcare professional embrace lifelong learning, crucial rapidly evolving complex field HCT CT. EBMT Educational Task Force EBMT educational task force led Scientific Council chair co-chair, Scientific Council educational representative, EBMT Medical Officer ensures involvement representative Working Parties, Nurses group, EBMT trainees, JACIE create wide spectrum educational content HCT CT provide resource professional development. task force also dedicated keeping healthcare professional updated latest trend advancement rapidly evolving field HCT CT harmonising educational practice Europe beyond. educational material provided include range resource joint WP meeting recordings, featuring interactive Q&A session live discussions, annual meeting recordings, topic-focused meeting well recommended publication guidelines. EBMT Exam Participating EBMT exam offer multitude benefit healthcare professional striving achieve high-quality education rapidly evolving field HCT CT. EBMT exam take place 51st edition EBMT Annual Meeting consist multiple-choice question English. Click know EBMT Exam! Educational Resources See information Resources produced, E-learning platform works. E-learning e-learning platform designedto reach EBMT member interested continuing education. Together collaboration EBMT Working Parties, topic interest established developed order realize possibility producing online courses. Members EBMT eligible reduced fee EBMT Annual Meeting educational event Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / EBMT Handbook manual choice doctor practitioner involved Hematopoietic Cell Transplantation (HCT) Cellular Therapies. thoroughly revised second edition EBMT Handbook address recent development innovation HCT cellular therapy, presented 200 authors, known expert well-recognised authority field. Download PDF free via button below. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / EBMT & JACIE Books EBMT publishes top international reference handbook HCT cellular therapy clinicians, researcher nurses. addition, JACIE offer book Quality Managers Inspectors. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / E-learning e-learning platform designedto reach EBMT member interested continuing education. Together collaboration EBMT Working Parties, topic interest established developed order realize possibility producing online courses. main advantage offered online learning flexibility student work want, possibility connecting wide-reaching network colleagues, peer expert field. selecting resource format course, ha expert committee considered developed topic question pedagogical strategy ha implemented. following first resource available platform EBMT members: Webinars: live online lecture various topic interest question participant end webinar. Nurses e-course: Spanish version EBMT LABMT e-course Data Managers e-course: focusing CAR-T cell therapy EBMT Online Learning Course Nurses:modular content based EBMT Textbook Nurses. Chimera: e-course trainee trainee Forum: place discuss, ask network. Blood Matters - Podcast Nurses: EBMT Podcast Nurses AHPs working instem cell transplantation cell therapy. JACIE Accreditation e-course Centres:open access course centre starting, already on, JACIE Accreditation journey. Additionally, learner earn certificate achievement upon completion e-courses include evaluation system. e-learning platform available EBMT members, course also open non-members. query please contact: View E-learning Courses Webinars Accessthe E-learning platform Sponsorship various opportunity support EBMT E-learning initiatives. information, please send email Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb / EBMT Exam Participating EBMT exam offer multitude benefit healthcare professional striving achieve high-quality education rapidly evolving field HCT CT. take Exam? Expertise validation EBMT exam serf comprehensive assessment tool, validating knowledge expertise healthcare professional field HCT CT. Successfully passing exam indicates high level proficiency. Certify knowledge HCT CT EBMT renowned international organisation. Attending exam provides recognised certification, enhancing opportunity collaboration worldwide scale. Stay Current Advances field HCT CT rapidly evolving. participating EBMT exam, professional ensure continuously updated latest research findings, technological advancements, treatment modalities. Professional advancement successful outcome EBMT exam significantly contribute professional advancement. Healthcare institution recognise importance specialised certifications, achieving distinction demonstrates commitment continuous learning, professional growth, excellence. Quality Patient Care knowledge learned pas EBMT exam increase quality care provided patient undergoing HCT CT. EBMT exam designed for? EBMT exam intended haematologists, residents, fellows, trainee HCT CT fields. learning materials? learning material preparation EBMT exam e-learning course based newly released EBMT handbook, backbone EBMT education activities. However, updated new educational resource uploaded regularly theeducational library April December 2024. how? EBMT exam take place 51st edition EBMT Annual Meetingand consist multiple-choice question English. Quality & Certification Quality assurance guarantee high scientific educational standard examall question reviewed expert field HCT CT. EBMT Official Certification Participants pas exam receive official EBMT certificate. detail preparation course EBMT exam provided shortly! Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nurses Group EBMT Nurses Group brings together nurse allied health professional working field haematology HCT. mission Nurses Group improve care patient evidence-based practice enhance value nursing role worldwide supporting sharing knowledge communication, advocacy, research, training education. Educational Resources development excellent educational resource nursing professional around world one top priority Nurses Group. addition new EBMT Nurses Textbook, published first time 2018, developed series online Learning Programmes material designed improve patient care share current knowledge best practises. Members EBMT eligible reduced fee EBMT Annual Meeting educational event Nurses Group News Patient Engagement EBMT Patient Engagement taskforce ha created promote active participation hematopoietic cell transplantation cell therapy recipient within EBMT. taskforce composed multi-disciplinary team made patients, caregivers, donors, healthcare provider stakeholder involved transplantation cell therapy. Patients & Donors page Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nurses Group - last two decades, support medical colleagues, BMT nursing ha grown rapidly ha acknowledged need care patients, family donors. Nurses taking leading role holistic care patients; BMT nurse involved decision-making process treatment option patients, evidently contribute enhancement patients' quality life. Learn Board, Committees, National Groups Regional Forums. Nurses Group Board Michelle Kenyon President Nurses Group United Kingdom Hilda Mekelenkamp President-Elect Nurses Group MEMBER NG SCIENTIFIC COMMITTEE Netherlands Elin Ofverberg Secretary Nurses Group MEMBER NG GLOBAL EDUCATION COMMITTEE Sweden Nurses Group Committees four Nurses GroupCommittees subgroup EBMT NursesGroup dedicated achieving goal EBMT NursesGroup specific areas. Click information. National Groups & Regional Forums currently 11 recognised national groups/regional forum affiliated EBMT NG, aim expand activity national international level. Learn clicking link below. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Working Party Nurses Vital keeping close contact EBMT Working Parties (WP) scientific agenda Working Party Nurses. WP Nurses manage nursing research nursing education activity within WP, supervision Research Committee (RC) Scientific Committee (SC) respectively. such, WP Nurses contribute research education agenda EBMT NG RC, SC Working Party. addition, WP Nurses offer support guidance development research study educational initiative promote opportunity nursing research within WP collaboration dissemination. Team Kelly Hennessy SAAWP Nurse United Kingdom Ariadna Domnech ADWP Nurse Spain Maaike de Ruijter CMWP Nurse Netherlands Ruth Clout CTIWP Nurse United Kingdom Marina Ben Izhak IEWP Nurse Israel Sophie Van Lancker TCWP Nurse Belgium Jenni Davies LWP Nurse United Kingdom Ida Bremer Ophorst PDWP NURSE CHAIRPERSON NG PAEDIATRIC COMMITTEE Netherlands Sandrine Bremathas HWP NURSE United Kingdom Main Activities promote nursing research strategy awareness within WP carry research adding body knowledge appropriate area make contribution strategic development within EBMT NG RC WP support research collaborative partnership support dissemination research finding publication writing, teaching, presentation conference appropriate contribute research within EBMT NG RC WP, collaborating development joint proposal project work promote nurse investigator within research assist development delivery educational initiative promoting nursing issues, line EBMT NG WP appropriate duty determined EBMT NG RC SC Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nurses Group Research Committee Research Committee group clinical nurse research specialist working develop research projects, promote awareness research activities, facilitate/support active participation research EBMT-NG members. Research Committee ha established number projects, presentations, publications. Examples completed activity include programme work looking adherence oral medication, management oral mucositis survey guideline management CVCs. Current research project NG-Research Committee focusing include: Management related donor including ethical issue management ATG administration JACIE-accredited centre Sexuality issue stem cell transplant recipient partner Risk infectious complication adult patient HSCT depending site CVC insertion. Multi centre retrospective study collaboration IDWP role nursing care patient skin cutaneous chronic Graft versus Host Disease (ccGvHD) post allogeneic haematopoietic stem cell transplantation (HSCT) Infection prevention control nursing practice training need assessment BMT unit Low Middle Income Countries(LMICs) cross sectional survey collaboration Global Education Committee IDWP Variability Nutritional Practices Peritransplant Period Allogeneic Hematopoietic Stem Cell Transplantation: Survey Transplant ComplicationsWorking Party EBMT. collaboration TCWP. Nurses Group Research Team Annika Kisch CHAIRPERSON NG RESEARCH COMMITTEE Sweden Lynn Leppla MEMBER NG RESEARCH COMMITTEE Germany Isabel Salcedo MEMBER NG RESEARCH COMMITTEE Spain Sabine Valenta MEMBER NG RESEARCH COMMITTEE Switzerland Simona Calza MEMBER NG RESEARCH COMMITTEE Italy Brian Piepenbroek SAAWP STUDY COORDINATOR LEAD Nurses Group Study Coordinator Lead Leiden, Netherlands Jarl Mooyaart CTIWP & Nurses Group Biostatistician Leiden, Netherlands Committee Objectives lead coordinate development nursing research within BMT/SCT. support member developing research. increase capacity research within NG members. Activities Develop research protocol within committee. Support Members develop approved protocols. Collaborate EBMT WPs provide nursing input study liaise relevant NG studies. Publish present result completed work. Provide research knowledge education presentation NG members. Upcoming project Review capacity nursing field within MED A/B data collection form facilitate effective process future research Increased collaboration Pharma company Link nurse EBMT WP work part RC Nurses Handbook app Survey safe transfer patient BMT ICU collaboration Paediatric Nurses Committee. Get involved would like become involved activity group; idea future project require help completing form please contact . News Publications Studies Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nurses Group Scientific Committee Scientific Committee (SC) dedicated group experienced nurse Europe specific interest haematology stem cell transplantation. complement different specialties, working nurse specialist, nurse coordinator nurse hospital ward, apheresis unit, outpatient clinic and/or consultation unit. Scientific Committee responsible nurse-oriented scientific program EBMT Annual Meeting. 4-day meeting take place every year March April different European country. member begin planning EBMT Annual Meeting May. November meet review submitted abstract nurse allied health care professional would like present research, nursing project developing work field haematologic stem cell transplantation annual meeting. Nurses Group Scientific Team Marijke Quaghebeur CHAIRPERSON NG SCIENTIFIC COMMITTEE Belgium Sandra Schoenfeld Member NG Scientific Committee Switzerland Daniel Kisielewski Next Generation Nurse Representative Germany Hilda Mekelenkamp President-Elect Nurses Group MEMBER NG SCIENTIFIC COMMITTEE Netherlands Thomas Jzquel French EBMT Nurses Group Chair MEMBER NG SCIENTIFIC COMMITTEE France Lorna Welsh Congress Local Nurse United Kingdom Committee Objectives ambition Nurses Group nurse allied health care professionals, regardless experience within field haematologic stem cell transplantation, learn something new annual EBMT meetings. aim empower bring home improvement idea quality care enhanced practice. second aim engender confidence presenting poster oral session new experienced nurse allied health care professionals. Activities Meetings person communication email provide EBMT Annual Meeting quality nurse-oriented scientific program Reviewing submitted abstract nurse allied health care professional would like present research project Upcoming project Preparing nurse-oriented scientific program next EBMT Annual Meeting Frankfurt March 2019 Collaboration would like become involved activity group, query comments, please send email Chair. News Publications Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nurses Group Paediatric Committee Paediatric Nurses Committee wa established 2008 within Nurses Group EBMT. committee dedicated improving care paediatric adolescent haematology stem cell transplantation patients. Nurses Group Paediatric Team Ida Bremer Ophorst PDWP NURSE CHAIRPERSON NG PAEDIATRIC COMMITTEE Netherlands Marjola Gjergji MEMBER NG PAEDIATRIC COMMITTEE Italy Maria Finch MEMBER NG PAEDIATRIC COMMITTEE United Kingdom Committee Objectives promote, develop share knowledge experience paediatric nurse throughout Europe, developing country within EBMT. Activities Prepare conduct paediatric session EBMT Annual Meeting. Collaborate closely Paediatric Diseases Working Party annual Paediatric Meeting Training Course Paediatricians Paediatric Nurses HSCT. Encourage networking among European nurses. Collaboration Outreach Program. Upcoming project Study: Get involved would like become involved activity group, idea future project queries, please contact Chair. News Publications Studies Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nurses Group Global Education Committee Global Educational Committee collaboration EBMT NG President, Committees various Nurse Groups, aim coordinate organize outreach meeting cooperation non-profit association mission objectives. Together coordinate provide range educational activity nurse allied health professional within field Haematology Haematopoietic Stem Cell Transplantation. committee meet twice yearly, EBMT Annual Meeting March/April Board & Committees Meeting September/October. Nurses Group Global Education Team Julia Ruz Pato CHAIRPERSON NG GLOBAL EDUCATION COMMITTEE Quality Manager & JACIE Inspector Spain Elin Ofverberg Secretary Nurses Group MEMBER NG GLOBAL EDUCATION COMMITTEE Sweden Angela Leather MEMBER NG GLOBAL EDUCATION COMMITTEE United Kingdom Committee Objectives play key role organisation educational HSCT Nursing event low-and-middle-income countries, collaboration like-minded entities. Activities Designing programme Nurses' Education/Training Day Cooperate non-profit association Contribute fundraising outreach mission Share information update rest committee member relevant collaborators. Upcoming project Upcoming study: Infection prevention control nursing practice training need assessment BMT unit Low Middle Income Countries (LMICs) cross sectional survey collaboration Global Education Committee IDWP Collaboration would like become involved activity group, idea future project queries, please send email Chair. News Publications Related document Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nurses Group Research guidance NursesGroup Research Committee, NursesGroup ha become actively involved pursuing clinical research agenda. number publication resulted activity. Publications Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nurses Group Education EBMT Nurses Group firmly belief investing research education together EBMT Working Parties Committees, care patient improved. form basis group primary objectives. Furthermore, Board ha taken initiative get involved Educational Committee order work combined education contribute EBMT Handbook. educational project included work Immune Thrombocytopenia (ITP), Chronic Myeloid Leukemia (CML), Adherence Compliance Chronic Lymphocytic Leukemia (CLL), Bone Health Multiple Myeloma (MM), among others. Learning Programmes EBMT Nurses Group ha developed number Learning Programmes topic Immune Thrombocytopenia CML downloaded module studied leisure E-learning programmes. Click learn gain access materials. Practical Guides Nurses Group ha also created several set Practical Guides nurse andhealth care professional variety topic variety languages. Click link access materials. Immune Effector Cell Nurses new forum ha created provide Nurses AHPs involved care patient treated IEC Therapy platform learn communicate colleague around globe. forum includes multiple discussion spaces, also news update EBMT, bank recommended publication useful resource support professional practice. goal forum create community professional working IEC Therapy, enable goal made forum open EBMT member well non-members. Web Learning number presentation past event accessed online various E-Materials platforms. Visit link event interest you. EBMT Nurses Group publishes EBMT Nurses' Textbook, first book written nurse working HSCT field. Webinars Beginning April 2020, EBMT LABMT begin offering live webinars nurses, hosted experts, EBMT LABMT members. Nurses Group Videos Educational Material Nursing Group ha created amassed substantial amount additional information useful patient practitioners. guides, videos, document presentation gathered document center searched filter document type event. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Nursing Events EBMT Nurses Group organises, regular basis,events trainingsfor nursing staff allied health care professionals, order optimize treatment care adult paediatric patient families. Specialist nurse physician provide update recent development andthe management haematological disorders, well present topic surrounding haematopoietic stem cell transplantation clinical practice today. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Immune Effector Cell Forum Welcome IEC Forum! "I would like invite nurse AHPs working area Immune Effector Cells join EBMT IEC forum. position learn rapidly evolving area cellular therapy. looking forward seeing forum develop." - Ruth Clout,Cell Therapy Immunobiology Working Party Nurse. aim forum? aim forum create global support network nurse allied health professional (AHPs) involved care patient treated potentially treated Immune Effector Cell Therapy stage patient pathway. also include nurse AHPs referring centre interest area. predominantly web-based resource area publicly available password protected private section foster open dialogue nurse AHPs seek peer support le public environment. doe forum Include? forum designed space professional working space IEC form community open dialogue practice. support created forum space variety topics, as; referrals, toxicities, follow-up care, late complications. Alongside topics, member encouraged share start discussions. hope space provide opportunity connect colleague around world, way able before. field ever-changing, support member providing relevant update EBMT topic Immune Effector Cells. located one space easily accessible member within IEC Forum. Finding relevant publication time consuming, remedy created space access continuously evolving list recommended publication topic Immune Effector Cells. constantly updating list hope use practice. encourage member discus thought publication forum space. included space able access range educational resource expert recommend professional development. Like aspect forum, new exciting resource added forum develops. access E-learning Platform? IEC Forum open EBMT member non-members EBMT E-learning Platform. access forum need enroll user, refer tutorial help this. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb JACIE JACIE develops maintain global standard provision quality medical laboratory practice cellular therapy. Based standards, JACIE offer accreditation transplant programme order encourage health institution facility establish maintain quality management system impacting aspect activity engage continuous improvement. JACIE's primary aim promote high quality patient care laboratory performance collection, processing transplantation centre internationally recognised system accreditation. JACIE committee EBMT, part fiscal legal identity. Members appointed accountable EBMT Board. ISCT represented two member Committee. JACIE name logo registered EBMT European Intellectual Property Office registration number respectively. Partners EBMT European Society Blood Marrow Transplantation (EBMT) non-profit organisation based Maastricht, Netherlands, wa established 1974 order allow scientist physician involved clinical bone marrow transplantation share experience develop co-operative studies. EBMT aim promote aspect associated transplantation haematopoietic stem cell donor source donor type including basic clinical research, education, standardisation, quality control, accreditation transplant procedures. ISCT Established 1992, ISCT global steward fostering cell gene therapy translation clinic. network leading clinicians, regulators, researchers, technologist industry partners, ISCT member shared vision translate cell gene therapy safe effective therapy improve patient life worldwide. ISCT global leader focused translational aspect developing cell-based therapeutics, advancing scientific research innovative treatment patients. ISCT provides unique collaborative environment address three key area clinical translation: Academia, Regulatory Commercialization. long term strategic relationship global regulatory agencies, academic institution industry partners, ISCT lead advancement research clinical adoption standard care. Comprised 2400 cell therapy expert across five geographic region representation 60 countries, ISCT member part global community peers, thought leader organization invested cell therapy translation. information organization, key initiative upcoming meetings, please visit:,. JACIE Process objective document togive introduction JACIE standard JACIE accreditation process. read background information, JACIE Standards, JACIE Accreditation Process role inspectors. Collaboration JACIE, part EBMT, ha regularly participated project initiatives. list project JACIE and/or EBMT contributed contributing. External Recognition European Union JACIE Accreditation Programme wa supported 2004 European Commission Public Health Programme 2003-2008 (Project No. 2003208). 2011 review spending Public Health Programme, JACIE wa highlighted exemplary project: "The JACIE project considered outstanding example EU funding facilitate harmonisation, implementation use common standards. also outstanding continuing activity end project period success regard international collaboration contribution public health policy regulation" (p.79) Download report below. National Regulations & Guidelines learn JACIE accreditation implemented incorporated national regulation andguidelines individual country international bodies, visit Regulations & Guidelines page below. JACIE Annual Activity Reports JACIE Annual Activity Reports included within EBMT Organisation Annual Reports Suggestions, queries, complaint order support quality continuous improvement JACIE accreditation programme, encourage contact u suggestions, query would like report incident complaint. query complaint received, acknowledgment receipt issued, stating date receipt. Next, JACIE investigate incident provide accurate detailed response findings. issue identified, JACIE endeavour resolve soon possible ass measure avoid repetition future. suggestions, query would like report complaints,please clickthe Contact u button complete form JACIE Office respond shortly. Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb JACIE Standards Standards cornerstone JACIE accreditation program. Believing quality care achieved clinical laboratory issue effectively addressed, FACT-JACIE Standards set requirement include clinical laboratory practices. Standards currently apply Hematopoietic Progenitor Cells (HPC) obtained bone marrow, peripheral blood, umbilical cord blood. JACIE Standards Editions Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb 8th edition FACT-JACIE Standards See information 8th edition. FACT-JACIE International Standards Hematopoietic Cellular Therapy Product Collection, Processing, Administration, eighth edition includes hematopoietic progenitor cell (HPCs), nucleated cell mononuclear cell hematopoietic tissue source collected therapeutic use HPCs, immune effector cell (IECs), genetically modified cells. sixth collaboration publish comprehensive quality-based Standards cellular therapy Foundation Accreditation Cellular Therapy (FACT) JACIE, Joint Accreditation Committee ISCT EBMT European Society Blood Marrow Transplantation (EBMT). FACT wa founded 1996 American Society Transplantation Cellular Therapy (ASTCT) International Society Cell Gene Therapy (ISCT), published first edition Hematopoietic Cell Standards year, initiated North American inspection accreditation program based Standards 1997. JACIE wa established 1999, adopted first edition FACT Standards, jointly reviewed second edition 2002. Subsequent edition Standards jointly developed, approved, published FACT JACIE. objective FACT-JACIE International Standards Hematopoietic Cellular Therapy Product Collection, Processing, Administration promote quality medical laboratory practice hematopoietic progenitor cell transplantation therapy using hematopoieticderived cellular products. FACT-JACIE Standards unique depth breadth, applicable phase cell collection, processing, storage, transportation, administration, phase clinical application including standard care therapy products, product administered regulatory-approved clinical trials, licensed (or regulatory approval) products. Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Applicants Accreditation mean centre demonstrate performing required level practice accordance agreed standard excellence certify operates effective quality management system. applying JACIE first time re-accreditation, encouraged download read JACIE Applicants Guide. Applicants Guide give general overview JACIE Accreditation process - taking initial stage thinking applying JACIE, Inspection process, achieving JACIE Accreditation. looking guidance establishing Quality Programme center, Quality Management Guide designed assist development maintenance Quality programme area Peripheral Blood Bone Marrow Stem Cell Transplantation. Additionally, 20/10/2023 JACIE launched e-learning course designed centre starting, already on, JACIE accreditation journey - whether first fifth time. course aim help staff working centre feel confident preparing undergoing JACIE Inspection addressing many frequently asked questions. JACIE make use Sharepoint environment share document inspector centres: order conduct process JACIE offer license free cost Office 365. guide available user check access Microsoft Office 365 services. apply step apply accreditation are: Submit application form. Sign Accreditation Agreement EBMT Submit pre-inspection documentation Go on-site inspection & receive Inspection Report Attend reporting corrective action (where indicated) Receive accreditation maintain accreditation first-time applicants, form checklist give JACIE necessary information ass centre eligible accreditation understand structure centre programme relationship institutions. renewal applications, may submit Inspection Checklist later stage reapplication process, together pre-inspection documentation. Note always important start completing checklist submit application form reduce amount time required preparing inspection documentation. Note thatAccredited Centres longer required submit Annual Report. are, however, required proactively inform JACIE change centre program. information Changes Form available Step 6 the. Translation Center's document Documents language spoken centre since JACIE would expect assign inspector speak understand language. However, may exception this: Centre located country inspector available; JACIE may inspector anywhere speak centre language; transplant community given country ha requested external inspector assigned, avoid conflict interest cases, must resort inspector perform inspection. inspectors, one key part preparation reading document made available advance. Without documents, difficult arrive on-site adequately prepared, would clearly affect quality inspection. cases, JACIE ask centre translate selection document provided inspector advance inspection request centre provide local expert facilitate interview understanding documentation. Please contact Accreditations Coordinator concern part process. English/Spanish Glossary term Alliance Harmonisation Cellular Therapy Accreditation (AHCTA) Worldwide Network Blood & Marrow Transplantation (WBMT) along Latin American Group Bone Marrow Transplantation (LABMT) facilitated preparation simple glossary quality management terminology help create awareness understanding basic important quality management terminology among Spanish-speaking transplant professionals. External consultant many provider company offering consultancy service implementing quality management healthcare. Many offer preparation JACIE accreditation among services. provider usually offer service return fee paid hospital. recognised provider often perform valuable service enable transplant programme prepare accreditation, noted neither JACIE EBMT endorse individual providers. organisation considering using service inform fully providers' capacity, knowledge experience way would ass service. Quality Managers centre member EBMT, standard membership fee 900 per annum includes quality manager additional cost. Check team, already included, ask Principal Investigator request EBMT Executive Office add membership listing writing . Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Inspectors Inspectors backbone JACIE; without them, accreditation process. Becoming inspector wonderful way contribute maintaining global quality standards, offer discount accreditation centre whose staff participated inspection event(s) 4 year prior submission. List registered JACIE inspector Access up-to-date list JACIE inspector below, organized city, country inspector area(s). list updated monthly. Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Become Inspector inspector shall following characteristics: openminded approach inspection standards; commitment JACIE (standards, processes, deadlines); team spirit; good communication interpersonal skills. Read learn qualification become inspector understand task inspector performs, follow step apply. Minimum Qualifications inspector shall completed training course new inspectors, passed associated exam based Standards complete periodic inspector training module prepared JACIE. inspector shall complete sign statement effect she/he qualified medical/scientific training experience JACIE inspector. inspector recommended tobe member ISCT, EBMT, similar society association. JACIE happy consider candidate inspector retired day-to-day clinical laboratory duties, 5 year retirement date. also additional minimum qualification following type inspectors: Clinical Transplant Program Inspector inspector shall hold medical degree, currently licensed practice medicine, specialist-trained certified one following: Haematology, Medical Oncology, Paediatric Immunology, Paediatric Haematology/Oncology Evidence minimum five year clinical blood marrow transplant experience consultant/specialist role (periods intern/resident training considered). JACIE may request clear breakdown period managing transplant patient and/or written confirmation experience supervisor. Haematopoietic Progenitor Cell Collection Facility Inspector inspector shall hold medical degree degree relevant science five year experience haematopoietic cell collection procedures, including apheresis. physician, currently licensed practice medicine. Or, shall five year experience nurse technician supervising collection peripheral blood progenitor cell apheresis. Cell Processing Laboratory Inspector inspector shall hold medical degree PhD professional degree biological science medical technology Five year experience Laboratory Director, Medical Director, Supervisor HPC Laboratory. Quality Management Inspector inspector Quality Management shall 3 year experience Quality Manager accredited centre preparing centre accreditation Provide letter Programme Director confirming experience able show evidence (documented) continuous education training quality management. include internal external training. Inspector's Job Description useful understand role task inspector carry out. Steps apply 1. Access completethe online Inspector Registration Form below, please sendcopies relevant medical qualification short version (including experience) CV JACIE offices. Submit document mail, emailto JACIE: JACIE Accreditation Office EBMT Executive Office Edifici Dr. Frederic Duran Jord Passeig Taulat, 116 08005 Barcelona (Spain) Email: 2. Complete JACIE Inspector Training Course 3. Complete JACIE Standards Exam. open-book exam time limitations. must complete first part section(s) exam, considered inspector achieve pas mark area indicated Inspector Registration Form suitably qualified experience training. Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb JACIE Inspector Handbook Handbook best reference inspector help guide stage JACIE inspection. JACIE inspector volunteer work field stem cell transplantation clinical, quality management (QM), nursing scientific roles. specific entry requirement would-be inspector defined job description different inspector role (Clinical, Collection, Processing QM). inspector may qualified inspect one area. example, clinician might qualified inspect clinical collection facilities. inspector asked commit 1-2 inspection per year. JACIE approach using volunteer subject-matter experts, ha vital transplant community accepting embracing inspection process, inspector part community peer clinician Allied Health Professionals (AHPs) working within centres. ha also allowed transplant community use JACIE educate Centres quality management system working best practice within field cell therapy. Moreover, ha helped standardise practice support ethos continuous improvement within transplant programmes. handbook intended ready reference inspector help guide task responsibility throughout stage JACIE inspection. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Current Inspectors following public list JACIE inspector monthly updated. Inspection Documents Inspections & Interim Audit following resource detail inspection process facilitate participation inspections, well provide information continuing education. Logistics travel agency, BCD Travel, get contact inspector JACIE office confirms inspection date. might request information (departure city, restrictions) propose itinerary accomodation inspector need confirm. Inspectors always requested arrive previous evening. JACIE make use Sharepoint environment share document inspector centres: order conduct process JACIE offer license free cost Office 365. guide available user check access Microsoft Office 365 services. Additional Guides & References additional guide handbook relating quality management available Document Centre. also peruse list external resource compiled. Inspectors Online Forum LinkedIn group dedicated JACIE inspector ha set up. Note access offered registered inspectors. Group's success depends willing member participate, please feel free raise question generate discussion. Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Inspector Committee JACIE Inspector Committee (JIC) important committee promoting JACIE Accreditation Programme helping develop strategy maintaining improving high level quality inspection making recommendation retaining committed, high performing pool inspector recruiting new inspectors. Inspectors backbone JACIE accreditation process, providing time expertise voluntarily. committee ha influential role within JACIE Accreditation Process term advancing inspection process, inspector pool strategic support continuing training education. Inspector Committee Team JIC consists Chair plus group expert representing different area based expertise JACIE inspectors: Clinical Adult Transplant, Clinical Paediatric Transplant, Haematopoietic Progenitor Cell Collection, Cell Processing Quality Management (see below) Eugenia Trigoso Arjona Chairperson Inspector Committee Spain Quality Management Inspector Committee Objectives Contribute development inspection format, including inspector team composition, checklist onsite inspection format. Making recommendation retention strategy order strengthen pool JACIE inspector maintain high performing pool inspectors. Making recommendation development continuing training education online in-person training formats. Committee Members Aurora Vassanelli MEMBER INSPECTOR COMMITTEE Italy Processing Quality Management Inspector Christopher Dean Dalley INSPECTOR COMMITEE MEMBER United Kingdom Clinical Collection Inspector John Fitzgerald INSPECTOR COMMITEE MEMBER Ireland Quality Management Inspector Lynn Manson JACIE Committee Chair Chairperson Accreditation Committee Inspector Commitee Member United Kingdom Collection Inspector Sandra Loaiza INSPECTOR COMMITEE MEMBER Accreditation Committee Member United Kingdom Processing Inspector Dania Arabi Inspector Committee Member Accreditation Committee Member Saudi Arabia Processing Quality Management Inspector Fabio Culurgioni INSPECTOR COMMITTEE MEMBER Italy Processing Quality Management Inspector Olga Lpez Villar Inspector Committee Member Accreditation Committee Member Spain Collection, Processing Quality Management Inspector Renza Monteleone QM Member JACIE Accreditation Committee INSPECTOR COMMITEE MEMBER Italy Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb JACIE Education JACIE organises regularinspector centre training courses. interested JACIE training, please write register directly individual event page. Read training format below: JACIE Accreditation e-course - check built centre starting, already on, JACIE accreditation journey JACIE Inspectors Webinars- JACIE Inspector Committee ha launched series session offered inspector starting June 2021. webinars periodical see . E-learning -The e-learning platform designed reach EBMT member interested continuing education. find. EBMT Annual Congress - congress feature dedicated JACIE session wider Quality Management Meeting addressing variety topics. JACIE Educational Materials Explore variety material past events, well training document produced department. Access sample below, see Document Centre more. 22-05-2017 JACIE Regulations Europe worldwide: Talk given part 2nd Kaunas International Haematology/Oncology Colloquium "New treatment modalities: molecular cellular therapies" (Kanaus, Lithuania) 25-06-2014 Basic introduction JACIE accreditation Latin American transplant centre (in Spanish) Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT Registry EBMT Registry, established 1974, backbone EBMTs research educational activities. provides pool data haematopoietic cell transplantation (HCT) healthcare professional perform studies, ass epidemiological trends, ultimately improve care patient haematological malignancy life-threatening disorders. 2023, EBMT Registry ha acquired data 700,000 patient received HCT procedure well data 4,000 patient received CAR T-cell therapy. thanks reporting done members, order retain full EBMT membership status, must report consecutive HCTs year. EBMT Registry contains patient clinical data, including aspect diagnosis disease, first-line treatments, HCT cell-therapy-associated procedures, transplant type, donor type, stem cell source, complication outcome. Patients followed indefinitely. Basic donor information included procedures, donor follow-up data entered transplant centre (or Donor Registry, unrelated donors). EBMT Registry study performed supervision EBMT Working Parties. EBMT Membership EBMT member centre access EBMT Registry. Find centre become member EBMT. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Information Patients & Donors Improving patient life ultimate objective EBMT community. patient organisation, focused strengthening connection patient making relevant EBMT information accessible explaining role important EBMT resource Patient & Donor Registry JACIE accreditation body. page designed introduce material hope interest. COVID-19 BMT Patients context coronavirus disease (COVID-19), EBMT provides array useful information resources. EBMT Registry EBMT Registry largest patient database kind Europe. Since 1974, ha gathered information haematopoietic stem cell transplantation procedures, explicit permission patients, provides pool data EBMT member perform studies, prepare trials, knowledge field. ultimate aim improve quality life outcome patients. Patient Privacy Statement want know Registry? Watch video Patient Engagement Patients, caregivers, donor health care professional (HCPs) complementary strength common goal: optimal outcome transplantation cell therapy. EBMT Patient Engagement taskforce ha created promote active participation hematopoietic cell transplantation cell therapy recipient within EBMT. Patient Advocacy EBMT established Patient Advocacy Committee ensure patient perspective integrated EBMT activities. Patients patient advocate involved HSCT interested activity EBMT become Individual Members reduced fee JACIE Accreditation information doe JACIE accreditation mean patients? JACIE accreditation offer patient reassurance transplant unit working line international standard ha undergone rigourous inspection process. JACIE establishes minimum requirement facilities, education training, quality management, donor patient management care, good cell collection laboratory practice. Endorsed expert JACIE joint initiative European Group Blood & Marrow Transplantation (EBMT) International Society Cellular Therapy (ISCT), two leading scientific organisation area cellular therapy. association not-for-profit entities. International standard JACIE Accreditation based FACT-JACIE International Standards prepared leading expert North America, Europe regions. National regulation JACIE accreditation ha incorporated national regulation several European country included number national guideline bone marrow transplantation. 2004, JACIE received support European Union (EU). independent review EU-funded project period highlighted success JACIE importance. Experience JACIE ha received application centre facility 20 country Europe, Africa Asia ha performed than300 inspection since 2000. JACIE inspector expert BMT field. Publications Patient Guides & Documents following list guide material produced EBMT specifically patients, donors, families, well number external resource may useful patient donors. Donor Links World Marrow Donor Association (WMDA) ha wealth information useful donor patients. EBMT, Donor Outcomes Committee dedicated collecting robust data donor outcome developing recommendation based data. Visit corresponding page learn more. Patient Association List number patient association provide wealth information knowledge haematopoietic stem cell transplantation procedures. Peruse list find one country area. Advocacy Advocacy patient implicating legal regulatory environment work ha become increasingly important focus EBMT. EBMT Legal & Regulatory Affairs Committee ha established focus coordinate action around issues, currently participating four important initiatives: Innovative Medicines Initiative (IMI) consultation advanced therapy HARMONY project aim foster better access care patient various haematologic malignancy use big data. Partnership agreement ONT; EBMT FACT aimed ensuring ongoing improvement utmost quality clinical procedure necessary conducting HSCT. Meeting EBMT DG SANTE -evaluation existing tissue cell legislation begin 2017 Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Patient Engagement Taskforce mission EBMT Patient Engagement Taskforceis promote active, collaborative participation patients, donors, caregiver health care professional partner society's activities. taskforce multi-disciplinary team clinicians, researchers, healthcare professionals, patients, caregivers, donors, stakeholder involved transplantation cell therapy. Patient Engagement Taskforce Core Team Hlne Schoemans Survivorship Subcommittee Chair TCWP Patient Engagement Taskforce Coordinator Belgium @Hschoemans Bregje Verhoeven Netherlands @BregjeVerhoeve1 Nicolaus Krger General Representative EBMT Shanghai Office Registry Committee, HCT representative Hamburg, Germany Linda J Burns CIBMTR United States Individual Members Scroll page view list individual members. Objective Patients, caregivers, donor health care professional (HCPs) complementary strength common goal: optimal care therapyoutcomes. taskforces objective offer platform promote interaction patients/caregivers healthcare provider show added value approach. initiative lead new common integrated pathway within EBMT improvethe whole transplantation cell therapy process. Activities EBMT 47th Annual Meeting Oral presentation abstract presentation available on-demand throughout congress. information, please check . Special Session SS01: Sunday, March 14, 16:00 - 17:30, Auditorium 6 Plenary Session P3: Wednesday, March 17, 14:30 - 15:45, Auditorium 1 full content session remain available On-Demand Library May 17, 2021 virtual meeting platform. date content available EBMT Members e-Learning platform. 15th Patient, Family & Donor Day - Recorded presentation upcoming project EBMT Patient Reported Outcome Registry Project Provide patient-specific educational material (FAQ webpage, webinars, etc.) Promote collaboration member Increase patient/caregiver/donor contact database Strategy task force meet regular basis engaged representative multiple stakeholder group discus current projects. collaboration patient engagement initiativesis also ongoing promote international synergy. Achievements Pan-European umbrella patient organisation Need help get started ?If organisation missing list below, please send u email add on. Pan-European disease-specific organisation Organisations giving support patient engagement research initiative missing list below, please send u email add on. EU initatives involving patient hematology / cellular therapy initiative missing list below, please send u email add on. Patient support group linked HCT cellular therapy Taskforce Members Hlne Schoemans Survivorship Subcommittee Chair TCWP Patient Engagement Taskforce Coordinator Belgium @Hschoemans Bregje Verhoeven Netherlands @BregjeVerhoeve1 Nicolaus Krger General Representative EBMT Shanghai Office Registry Committee, HCT representative Hamburg, Germany Linda J Burns CIBMTR United States Bronwen Shaw CIBMTR United States John Murray EQUALITY, DIVERSITY & INCLUSION (ED&I) COMMITTEE DEPUTY CHAIR United Kingdom @johnerniemurray Michelle Kenyon President Nurses Group United Kingdom Sarah Hutton PATIENT ADVOCACY COMMITTEE MEMBER United Kingdom Sabina De Geest Nurse Switzerland Guy Bouguet PATIENT ADVOCACY COMMITTEE MEMBER France @lymphomeespoir Andrea Linke PATIENT ADVOCACY COMMITTEE MEMBER Germany Natacha Bolaos PATIENT ADVOCACY COMMITTEE CHAIR Spain @BolanosNat Chris Lewis Patient Advocate United Kingdom Founder Chris's Cancer Community @christheeagle1 Zinaida Peri TCWP Chair Acute Lymphoid Leukaemia Subcommittee Croatia John Snowden Member JACIE Committee United Kingdom Anna Barata Psychologist Moffit Cancer Center, Tampa, Florida, United States Isabelle Scholl Psychologist Universittsklinikum Hamburg-Eppendorf, Germany @IsabelleScholl Cristina Avendao Sol Puerta de Hierro University Hospital, Madrid, Spain William Boreland TCWP Study Coordinator Paris, France Emmanuelle Polge ALWP, TCWP, GoCART Clinical Data Specialist Paris, France Anja van Biezen Business Unit & EU Grants Manager Leiden, Netherlands Iris Bargall Arraut Data Protection & Quality Manager Barcelona, Spain Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu unique registry. vibrant scientific community. Fighting life-threatening blood cancer disease improving patients' lives. Science Education Patient Care EBMT Become Member EBMT gain access database kind Europe EBMT News Highlights Patient Care & Donor Information Access variety material information compiled patient donor mind. Fast Facts Patients 702,579 Registry Transplants 826,418 Registry Patients treated CAR T-cells 5,000+ Registry Accreditations 214 JACIE-accredited centre EBMT Partners Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu unique registry. vibrant scientific community. Fighting life-threatening blood cancer disease improving patients' lives. Science Education Patient Care EBMT Become Member EBMT gain access database kind Europe EBMT News Highlights Patient Care & Donor Information Access variety material information compiled patient donor mind. Fast Facts Patients 702,579 Registry Transplants 826,418 Registry Patients treated CAR T-cells 5,000+ Registry Accreditations 214 JACIE-accredited centre EBMT Partners Secondary 2024 EBMT. right reserved. Footer menu Search Follow Twitter Event landing menu Toggle main menu visibility 50th Annual Meeting EBMT 14-17 April 2024 | Glasgow Celebrating 50 Years Community Attendance 50th Annual Meeting EBMT 2024 opportunity connect cutting-edge scientific content related transplantation cellular therapy, network thousand top healthcare professional world, celebrate remarkable achievement European international transplant community past 50 years.... Join Scientific Community Glasgow Annual Meeting EBMT congress involved care transplant cellular therapy patients. dedicated session physicians, nurses, data managers, statisticians, quality managers, cell therapists, paediatricians, pharmacists, psychologists, psychiatrist psychoanalysts, transplant coordinators, lab scientists, trainees, patients. 5,500+ Expected Attendees 1,000+ Abstract Submissions 100+ Countries Represented Rewatch Congress On-Demand June Missed session presentation? Unlock On-Demand Content 50th Annual Meeting watch recording via Virtual Meeting Platform EBMT 2024 Appuntil 17 June 2024 23:59 CEST. Download Official EBMT 2024 App EBMT 2024 App best tool help enjoy 50th Annual Meeting mobile device. Click download Apple App Google Play stores! Explore Scientific Programme Local Organising Committee, together EBMT Scientific Council, ha designed outstanding programme cover key issue relating HCT cellular therapy research. Watch EBMT TV's Daily Episodes Interviews EBMT TV produced daily episode 50th Annual Meeting featuring conference news in-depth report collaboration international film broadcasting company WebsEdge. Visit EBMTs YouTube channel (@TheEBMT) watch episode interviews. Learn Annual Meeting Annual Meeting EBMT ha rich history 49 years. celebrate 50th anniversary Annual Meeting Glasgow Scottish Event Campus. Learn congress venue Annual Meeting clicking below. Quick Links Read latest EBMT 2024 news Certificate Attendance CME Points Certificate Attendance Certificate Attendance available within Virtual Meeting Platform sent via email participant attended congress final day 50th Annual Meeting (Wednesday, 17 April 2024). order download Certificate Attendance, kindlyask complete short satisfaction survey. recommend complete survey using computer order download Certificate Attendance successfully. EBMT issue certificate last five editions. information, contact secretariat@ebmt.org CME Accrediation programme 50th Annual Meeting EBMT, held Glasgow, United Kingdom, 14 - 17 April, 2024, ha reviewed andapprovedfor CME accreditation European Board Accreditation Hematology (EBAH) CME Unit. EBAH-CME Unit ha approved educational activity maximum number of26.5EBAH-CMEcredit pointsand time spent participant educational activity tracked purpose. participant may print EBAH-CME certificate, indicating number EBAH-CME credit point awarded, directly CME section EBAH website at. EBMT certifies content CME event without advertisement content presented scientifically neutral. certify speaker author disclose potential conflict interest appropriately. Watch On-Demand Content 50th Annual Meeting watch recording via Virtual Meeting Platform EBMT 2024 App. Thank interest 50th anniversary! Please note session presentation pending review speaker may consent publication content on-demand. platform on-demand content remain available 17 June 2024 23:59 CEST. Download Official Annual Meeting App best tool help plan day 50th Annual Meeting. inside app access virtual meeting platform well as: Easily save session create personal daily agenda. Receive reminder upcoming presentations. Browse scientific programme, ePosters, faculty, exhibitors, sponsors, floor plan more! Post Memories Social Media #EBMT24 Share favourite moment 50th Annual Meetingand add conversation social media! Include #EBMT24 tag @TheEBMT posts. Check Meeting Organisers EBMT Executive Office +34 93 453 8570 CME Congresses Useful Links Stay Updated Subscribe News & Updates list get latest information 50th Annual Meeting EBMT news events. 2024 EBMT. right reserved. Shortcuts Search Main navigation Menu Share: Breadcrumb / 3rd Joint ASTCT+EBMT Basic Translational Scientific Meeting Date: 15 May 2024 - 17 May 2024 Event type: Educational Meeting City: Washington DC Country: United States Joint ASTCT + EBMT Basic Translational Scientific Meeting isa 2.5-day conference focused cutting-edge basic translational biology field. meeting focus fundamental theme novel technology emphasis unpublished innovative science. Attendance meeting limited 100 attendee afternoon break allow informal networking opportunity junior senior attendees. meeting host two day poster session best oral abstract session. Please click button access updated preliminary programme. Abstract submission closed. ASTCT EBMT accepting abstract 2024 ASTCT + EBMT 3rd Joint Basic Translational Scientific Meeting taking place Washington, D.C. May 15 - 17, 2024. abstract submission window close onFriday, March 15th 5:00 p.m. CT. Abstract Submission Criteria Abstracts scored based following criteria: Importance Relevance: clear rationale work provided? study address important question? finding potential advance field blood marrow cellular therapies? Originality Innovation: work novel? present new finding and/or address problem using original improved approach? Quality Methods Writing: method well described valid answer question? abstract clear well written? abstract within 300-word limit? Please note abstract submission form doe tracker word count. recommend prepare abstract submission Word document confirm stay within 300-word limit. top-scoring abstract selected Oral Platform Presentations; top-scoring abstract selected Oral Platforms selected Distinguished Posters. Responsibility Abstract Authors Presenting Author responsible following: Ensuring author read abstract agreed co-authors. Notifying co-authors additions, deletions, change program, may communicated Joint ASTCT-EBMT Basic Translational Scientific Retreats. Obtaining conflict-of-interest disclosure information co-authors. Making certain abstract complete (tables included labeled) written clear, concise grammatically correct English, reviewer able focus solely scientific merit submission. author question regarding clarity, grammar spelling abstract, encourage identifying using independent reviewer edit abstract prior submission. Please contactwith question regarding submission. begin submission, asked "Name Entry", please use section include high level topic/area/theme submission address. Registration fee REGISTRATION RATES PRICE Standard Registration 400USD Trainee & Junior Faculty 275USD Allied Health Professionals 275USD *Junior attendee defined post doctoral fellows, current fellows, junior faculty within first three year appointment. Registration event limited maximum 100 total attendees. unable accept additional registrant registration capacity ha met. conference physician scientist arecurrentlypracticing field transplantation cellular therapy sponsoring companies. Please contact Angie Dahl () interested participating sponsor. Meeting Venue Hilton Washington D.C. National Mall Wharf 480 LEnfant Plaza SW Washington D.C. 20024 (202) 484-1000 Registered attendee receive housing link secure discounted room rate official registration confirmation email. Room Rate $329.00 plus tax per night (single/double). room rate increase $20 per night additional people. Housing Rate Cutoff take advantage discounted room rate, sure book reservation beforeApril 24, 2024. April 24, room block released negotiated room rate may available. Please make sure hotel aware special needs. assign specific room type request based availability. Deposits Please credit card information hand upon booking reservation. TheHilton Washington D.C. National Mall Wharfrequires individual reservation guaranteed deposit equal one night's room tax. Changes Cancellations TheHilton Washington D.C. National Mall Wharfrequires cancel reservation (72) hour prior arrival. deposit one night's room tax forfeited cancellation made le (72) hour arrival. Please call hotel directly make cancellation keep cancellation confirmation number records. Name change made reservation time prior check-in, without incurring fee. Confirmations hotel send confirmation email used booking reservation using customized online reservation link provided ASTCT-EBMT. Review carefully accuracy keep copy records. Nearby Things Discover the, event happening right annual festival much more. conference physician scientist arecurrentlypracticing field transplantation cellular therapy sponsoring companies. Please contact Angie Dahl () interested participating sponsor. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Share: Breadcrumb / / EBMT support International Thalassaemia Day 7 May 2024 EBMT Organization // Haemoglobinopathies Working Party (HWP) Emanuele Angelucci, Haemoglobinopathies Working Party Chair widely recognised, thalassaemia stand one significant devastating health challenge globally, contributing ten thousand new case year. past decade, prognosis thalassaemia ha undergone remarkable improvement, thanks collective effort researchers, doctors, patient associations. collaborative endeavour ha transformed thalassaemia lethal childhood disease manageable chronic condition, characterised prolonged survival open prognosis. However, progress necessitates substantial medical resources. three decades, allogeneic hematopoietic stem cell transplantation ha offered potential cure patient transfusion-dependent thalassaemia, albeit constraint donor availability procedural risks, particularly among adult patients. Recently, long-envisioned prospect gene therapy ha transitioned theoretical discussion tangible reality clinical trials, presenting promising option patients. 2023, EBMT established dedicated Working Party focusing haemoglobin disorders, including transfusion-dependent thalassaemia sickle cell disease. Haemoglobinopathies Working Party strives promote global dissemination curative treatment modalities, transplantation gene therapy, enhance clinical research endeavours, formulate indication criteria, improve standard care. Currently, six study underway, many pipeline. deeply committed fostering close collaboration thalassaemia specialist patient associations. Recognising true optimisation patient care achieved amalgamation efforts, knowledge, enthusiasm, Working Party endeavour identify suitable treatment option patient, right time. "Empowering Lives, Embracing Progress: Equitable Accessible Thalassaemia Treatment All" encapsulates shared objective medical association engaged complex compelling healthcare domain. Watch interview representative HWP discus howtreatment ha developed last 40 years, current treatment landscape feel hopeful patient future. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Share: Breadcrumb / / 2024 Election Results 23 April 2024 EBMT Organization Nurses Group // Autoimmune Diseases Working Party (ADWP) Infectious Diseases Working Party (IDWP) Lymphoma Working Party (LWP) eligible vote Principal Investigators (591) EBMT full membership centre invited vote online nominated, endorsed approved EBMT Secretary Working Party Chair candidate 2024, addition approving activity report (President, Secretary Treasurer). Voting took place online Friday 5 April Monday 15 April 2024. 169 ballot submitted 591 eligible voter = 29% participation. Please see result online election below: EBMT Secretary EBMT Secretary - Raffaella Greco Yes - approve candidate 164 vote (99.39%) - reject candidate 1 vote(0.61%) Yes - approve candidate win 99.39% vote. (165 vote tallied 4 abstentions) "It great honour privilege elected Secretary Executive Committee EBMT. Im highly motivated contribute core activity EBMT, fostering cross fertilisation, inclusion, innovation, promotion knowledge, basic clinical research, education, registry, guidelines, standardisation, quality control, accreditation transplant cellular therapy procedures. Central mission save life patient blood cancer life-threatening disease advancing field worldwide science, education advocacy. value totally reflect honoured promote community." EBMT Working Party Chairs EBMT Autoimmune Diseases Working Party Chair - Tobias Alexander Yes - approve candidate 148 vote (95.48%) - reject candidate 7 vote (4.52%) Yes - approve candidate win 95.48% vote. (155 vote tallied 14 abstentions) "I honoured elected position Chairperson ADWP. rheumatologist Department Rheumatology Clinical Immunology Charit Universittsmedizin Berlin working ADWP Secretary past 8 years. recent introduction CAR-T cell therapy targeted cellular therapies, new era treatment severe autoimmune disease ha begun. community autoimmune disease experts, along haematologist clinical immunologists, challenge integrate new therapeutic option changing landscape autoimmune disease treatments. looking forward driving forward, alongside colleague involvement patient advocate patient representatives, academic output working party. convinced resource ADWP EBMT overall, highly relevant evolution." EBMT Infectious Diseases Working Party Chair - Dina Averbuch Yes - approve candidate 137 vote (95.80%) - reject candidate 6 vote (4.20%) Yes - approve candidate win 95.80% vote. (143 vote tallied 26 abstentions) "Adequate diagnosis, prevention management transplant infectious complication paramount importance improve patient outcome following hematopoietic cell transplantation CAR-T therapy. IDWP believe collaborative effort study infection HCT patient share experience enrich knowledge field help patients." EBMT Lymphoma Working Party Chair - Ali Bazarbachi Yes - approve candidate 153 vote (99.35%) - reject candidate 1 vote (0.65%) Yes - approve candidate win 99.35% vote. (154 vote tallied 15 abstentions) "I deeply honored elected Chair EBMT Lymphoma Working Party (LWP). LWP one largest crucial working party EBMT, serving one pillars. support trust, anticipate leading collaborating want contribute success. LWP open interested parties, mandate perceived individual effort achieving goal requires well-structured team effort." EBMT Nurses Group EBMT Nurses Group President -Hilda Mekelenkamp Yes - approve candidate 41 vote (97.62%) - reject candidate 1 vote (2.38%) Yes - approve candidate win 97.62% vote. (42 vote tallied 3 abstentions) "It honour elected president-elect Nurses Group, grateful trust. eager promote supportive collaborative environment within EBMT, specifically nursing community, professional patient share experience best practice improve patient care continually. envision empowered, united nursing community forefront advancing health care. Together, strengthen professional roles, optimise care patient blood-related diseases, promote positive change nursing practice." EBMT Nurses Group Secretary - Elin fverberg Yes - approve candidate 41 vote (97.62%) - reject candidate 1 vote (2.38%) Yes - approve candidate win 97.62% vote. (42 vote tallied 3 abstentions) "It great privilege new EBMT Nurses Group Secretary. following Nurses Groups work many year became part NG Global Education Committee 2022. excited start journey new role NG Secretary. believe EBMT Nurses group important strengthening Nurses nursing field Hematopoietic Stem Cell Transplant, proud part future work group. Pediatric Nurse country small population, learned need across Europe beyond. need network collaborate. need moving forward, strong teamwork clear goal patient number one focus." EBMT Activity Reportsand Bylaw Amendment addition voting online nominated candidates, PIs also asked approve President's, Secretary's Treasurer's report Bylaw Amendment Approval Articles 8, Treasurer 9, Working Parties, advance Annual General Assembly Meeting 2024. EBMT President's Activity Report 2023 Yes - approve President's Activity Report 2023 164 vote (99.39%) - reject President's Activity Report 2023 1 vote(0.61%) Yes - approve President's Activity Report 2023 win 99.39% vote. (165 vote tallied 4 abstentions) EBMT Treasurer's Annual Report 2023 Yes - approve Treasurer's Annual Report 2023 158 vote (99.37%) - reject Treasurer's Annual Report 2023 1 vote(0.63%) Yes - approve Treasurer's Annual Report 2023 win 99.37% vote. (159 vote tallied 10 abstentions) EBMT Secretary's Annual Report 2023 Yes - approve Secretary's Annual Report 2023 156 vote (98.11%) - reject Secretary's Annual Report for2023 3 vote (1.89%) Yes - approve Secretary's Annual Report 2023 win 98.11% vote. (159 vote tallied 10 abstentions) Bylaw Amendment Approval Article8 Yes - approve amendment 156votes (99.36%) - reject amendment 1 vote(0.64%) Yes - approve amendmentwins 99.36% vote. (157 vote tallied 12 abstentions) Bylaw Amendment Approval Article 9 Yes - approve amendment 146 vote (92.41%) - reject amendment 12 vote (7.59%) Yes - approve amendmentwins 92.41% vote. (158 vote tallied 11abstentions) Outgoing Board Members would like tothank following outgoing Board Members support commitment Scientific Council Board Association mandates: John Snowden, EBMT Secretary, Member EBMT Executive Committee Member Board Association 2020-2024. Raffaella Greco,EBMT Autoimmune Diseases Working Party Chair 2020-2024, Member Board Association representing Scientific Council Education Portfolio 2022-2024, Practice Harmonisation Committee Vice-Chair. Rafael de la Cmara,EBMT Infectious Diseases Working Party Chair 2020-2024, Member Board Association representing Scientific Council Registry Portfolio 2022-2024. Bertram Glass, EBMT Lymphoma Working Party Chair from2020-2024. Daphna Hutt, EBMT Nurses Group Secretary from2020-2024. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Share: Breadcrumb / / Awards 50th Annual Meeting EBMT 22 April 2024 Research Nurses Group Events Transplant Activity Survey // Cellular Therapy & Immunobiology Working Party (CTIWP) Lymphoma Working Party (LWP) Paediatric Diseases Working Party (PDWP) Quality Managers Committee Pharmacist Committee Nursing Research Committee Nursing Scientific Committee Nursing Paediatric Committee Nursing Global Education Committee Activity survey office OPENING CEREMONY HONORARY MEMBERS:Arnon Nagler Jane Apperley EBMT 2024 Honorary Membership Arnon NaglerEBMT 2024 Honorary Membership Jane ApperleyCLINICAL ACHIEVEMENT AWARD:Achilles Anagnostopoulos Anne Parker EBMT 2024 Clinical Achievement Award Achilles AnagnostopoulosEBMT 2024 Clinical Achievement Award Anne ParkerDISTINGUISHED MERIT AWARD: Helen Baldomero Jakob Passweg EBMT 2024 Distinguished Merit Award Helen Baldomero & Jakob PasswegEBMT PHYSICIANS AWARDS VAN BEKKUM AWARDtoLeslie Kean (United States) abstract EBMT 2024 Van Bekkum Award Leslie Kean (right)BASIC SCIENCE AWARDtoHaroon Shaikh (Germany) abstract EBMT 2024 Basic Science Award left right:Charlie Craddock; Anna Sureda; Grant McQuaker; Haroon ShaikhJIAN-JIAN LUAN AWARD LYMPHOMA TRANSPLANT RESEARCHto Nora Liebers (Germany) abstract EBMT 2024 Jian-Jian Luan Award Bertram Glass (left) &Nora Liebers (right)JON J. VAN ROOD AWARDto Francesca Del Bufalo (Italy) paperGD2-CART01 Relapsed Refractory High-Risk Neuroblastoma EBMT 2024 Jon J. van Rood Award left right: Jrgen Kuball; Francesca Del Bufalo; Annalisa Ruggeri; Florent MalardJON J. VAN ROOD AWARDto Gabriele Casirati (United States) paperEpitope editing enables targeted immunotherapy acute myeloid leukaemia DIETRICH NIETHAMMER AWARD toFrancesca Del Bufalo (Italy) presentation titled: CAR-T cell relapsed refractory neuroblastoma hype hope? EBMT 2024 Dietrich Niethammer Award left right:Katharina Kleinschmidt; Francesca Del Bufalo; Krzysztof KalwakDIETRICH NIETHAMMER AWARD Robert Chiesa (United Kingdom)for presentation titled:Base edited CD7 CAR-T cell therapy relapsed T-ALL EBMT 2024 Dietrich Niethammer Award Robert ChiesaBEST YOUNG ABSTRACTS EBMT 2024 Best Young Abstracts Award11 BEST YOUNG ABSTRACT AWARDS Nico Gagelmann (Germany) - Christo Tsilifis (United Kingdom) - Haroon Shaikh (Germany) - Christo Tsilifis (United Kingdom) - Quentin Riller (France) - Mustafa Gven (Turkey) - Laura M. Moser (Germany) - L Marie Czech (Germany) - Lin Li (China) - Yishan Ye (China) - Qiaomei (China) - 5 BEST YOUNG POSTER AWARDS Jia Chen (China) - Sarah Weischendorff (Denmark) - Sheng Chen (China) - Juan Fernando Gamboa Vargas (Germany) - Filippo Frioni (Italy) - SPRINGER NATURE POSTER AWARDS EBMT 2024 Springer Nature Poster Awards: Maria Ester Bernando & Shu Ping WongBest Clinical Poster AwardtoShu Ping Wong (Malaysia) - Best Basic Science Poster AwardtoMaria Ester Bernardo (Italy) - EBMT NURSES GROUP AWARDS 16thDISTINGUISHED MERIT AWARDto Daphna Hutt EBMT 2024 Nurses Group 16th Distinguished Merit Award Michelle Kenyon (left)and Daphna Hutt (right)HONORARY MEMBER 2024toTheo Nering Bgel EBMT 2024 Nurses Group Honorary Membership Michelle Kenyon (left)and Theo Nering Bgel (right)BEST ADULT ORAL PRESENTATIONABSTRACT AWARD toKathy Goris (Belgium) - BEST PAEDIATRIC ORAL PRESENTATIONABSTRACT AWARDtoKatie Elwig (United Kingdom) - BEST RESEARCH ORAL PRESENTATIONABSTRACT AWARDto Lotte Kinds(Belgium) - EBMT 2024 Nurses Group Best Research Oral Presentation Lotte Kinds & Michelle KenyonBEST ADULT POSTER PRESENTATIONABSTRACT AWARDto Debbie Anderson(United Kingdom) - EBMT 2024 Nurses Group Best Adult Poster Debbie Anderson & Michelle KenyonBEST PAEDIATRIC POSTER PRESENTATIONABSTRACT AWARDtoAnnette Hill (United Kingdom) - EBMT PHARMACISTS AWARDS BEST PHARMACISTS' ABSTRACTS AWARDtoKhalil Ben Hassine (Switzerland) abstract EBMT 2024 Pharmacists Best Abstract Award Nick Duncan (left) &Khalil Ben Hassine (right)BEST PHARMACISTS' ABSTRACTS AWARD Heather Weerdenburg (Australia) abstract EBMT 2024 Pharmacists Best Abstract Award Heather WeerdenburgBEST PHARMACISTS' ABSTRACTS AWARD toSara Redondo (Spain)for abstract EBMT 2024 Pharmacists Best Abstract Award Sara RedondoEBMT QUALITY MANAGEMENT AWARD BEST QUALITY MANAGEMENT ABSTRACT AWARDto Florence Mesnil (France) abstract EBMT 2024 Best Quality Management Abstract Award Florence Mesnil (left) & Lynn Manson (right) Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu EBMT Annual Report 2022 Society Anna Sureda EBMT President Foreword EBMT President 2022 wa productive year EBMT community. Anna Sureda looking back EBMT achieved term science, education patient care. also taking opportunity thank party involved: EBMT Staff, Board, centre individual members, partner around world constant work dedication society. Last year, 2022, wa productive one EBMT community. ready see so-called new normal but, disappointingly, thein Prague switch virtual meeting. Although, stop us. second half last year, EBMT ha successful bringing many u together event across Europe. Theas well well attended represented excellent opportunity in-person networking interaction. sincere gratitude go active member Trainee Committee naturally incorporated rejuvenated flavour activities. write message, cannot help get excited hosted Paris online 23-26 April 2023. hope choose attend either in-person virtually. Another significant part activity 2022 consisted promotion development scientific, educational partnership opportunity related use CAR T-cells. ha exponential increase reporting CAR T-cell therapy proudly say reached 4,000 CAR T- cell treated patient within EBMT Registry (visit webpage information). Moreover, successful resolution three new winning projects, together increasing number retrospective analysis performed umbrella EBMT Working Parties will, without doubt, bring additional research help improve management long-term follow-up new treatment modality Europe. Also worth mentioning fact EBMT ha managed keep positive opinion EMA regarding cellular therapy module. actively conducted society five ongoing four additional one start-up/contracting phase. see activities, keen staying forefront rapidly evolving field. Partnerships collaboration also represented major asset community. regular meeting representative National Societies haematopoietic cell transplantation cellular therapy, fostered deeper level interaction closer communication, finished governance charter EBMT-EHA , consolidated educational activities, harmonised accreditation process CAR T-cell centre together industry partners. EBMT EHAs collaboration ha also crystallised propelled society host wonderful hybrid meeting Rotterdam February year (). Nonetheless, collaborative spirit EBMT go beyond European borders. Joint Scientific Retreat EBMT ASTCT ha one best examples; three day excellence, sharing knowledge, learning challenging concepts, giving scientific career advice. Likewise, collaboration China wa amplified last year theheld November 2022. addition, witnessed increasing number Chinese centre becoming full member EBMT well scientific collaborative output. brings great joy know community growing activity greater impact year year. response Russian invasion Ukraine devastating impact civilian patient affected regions, EBMT immediately set initiative called the. ha continuously active throughout 2022 ha constructed discussion forum potential candidate cellular therapy strategies. Unfortunately, though, war continues. Last year, 2022, ha left many dead, many family divided, others homeless. continues constitute one important humanitarian crisis recent years. EBMT continue support Ukrainian people always mission vision society continue encourage transfer scientific knowledge among members. JACIE, pandemic, clear challenge resolve. However, already seen high level enthusiasm commitment everyone involved find solution challenge current processes. work doe go unnoticed. JACIE team completed 64 full inspection 80 initially expected. Moving forward, second EBMT benchmarking exercise ha paved way second manuscript (published March 2023). Yet, feasibility, acceptability reliability system ha supported limitation identified. cannot wait see impact JACIE team 2023. Looking ahead, must remain committed completing current project time, also embrace execute new ones. Certainly, one u concentrating EBMT Registry upgrade project, launched late summer 2023. Plus, focus recently EU funded project unquestionably strengthen link EBMT National Registries/Societies term data harmonisation sharing. also passionately working finalising EBMTs Strategic Plan 2023-2026, emphasis renovating upgrading way EBMT approaching Science, Education Quality Care Accreditation order make society aligned partner stakeholder needs. Still, none achievement could possible without collaboration efforts. would like express sincere appreciation EBMT Staff, EBMT Board, EBMT centre individual members, plus partner around world constant work dedication society. strong community, story 2023 even successful. Thank much! Anna SuredaEBMT President Read Read le EBMT Annual Report 2022 Science introduction scientific report always little reflection ha happened scientific society achieved. importantly, COVID-19 lost horror pandemic turned one recurrent viral infections... . Working Parties Activity Reports science Committees Activity Reports EBMT Annual Report 2022 Education EBMTs Education Events Department, 2022 wa start new normal. started year three virtual Working Party meetings, held theCellular Therapy & Immunobiology, Chronic Malignancies, Severe Aplastic Anemia Working Parties. InFebruary, EBMT EHA jointly organised fourth edition European CAR T-cell Meeting. wa second fully virtual edition event, due concern regarding winter COVID wave... . Educational activity Committees Activity Reports EBMT Annual Report 2022 Patient Care & Advocacy Improving care patient critical objective EBMT. believe empowering, advocating amplifying interest patients, survivors, caregiver worldwide. sure catch activity Nurses Group, JACIE, GoCART Coalition EBMT Legal & Regulatory Affairs Committee throughout past year. Patient Care & Advocacy Initiatives Committees Activity Reports Financial Report & Highlights 2022 last four year EBMT Treasurer, EBMT substantially secured financial model, allowed investment strategic mission goal creation continuous reserve income society, strategic project staff positions... Society Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb News & Updates form browser doe support iframes, visit Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Area - -EBMT OrganizationResearchRegistry/Data ManagementNurses GroupEventsTraining/EducationAccreditationPatients & DonorsTransplant Activity Survey Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Document type Corporate (Annual reports, minutes, ToRs, etc.)Forms, Checklists & TemplatesGuidelines, Consensus Statements & Position PapersNewsletterPress ClippingPress ReleaseProtocol/Study informationTraining/Education MaterialsTraining/Education Presentations & AbstractsUser guides/Instructions Event type - -EBMT Annual MeetingBusiness MeetingEducational MeetingTraining Course Creation date Language - -EnglishArabicCroatianCzechDanishDutchEstonianFinnishFlemishFrenchGermanGreekHebrewItalianJapaneseLithuanianMandarinNorwegianPolishPortugueseSlovenianSpanishSwedishTurkish Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT Textbook Nurses New translation EBMT Nurses Textbook Italian, French, German available! Spanish translation also coming soon. Open Access Second Edition textbook, endorsed EBMT, provides adult pediatric nurse full informative guide covering aspect transplant nursing including new chapter dedicated cellular therapy, nursing implication care. book take reader basic principle advanced concept journey history transplant nursing, including essential progressive element help nurse improve knowledge benefit patient experience, well comprehensive introduction research auditing methods. second edition specifically intended nurses, complement EBMT Handbook, popular educational resource originally developed 2003 physician accompany annual training course also serving educational reference tool right. title designed develop knowledge nurse transplantation. one kind written nurse experts, specifically targeted nurse specialist field acknowledges valuable contribution nursing make patient care area. new volume present updated content essential education nurse new transplantation, also offering valuable resource experienced nurse wish refresh knowledge. Translations Texbook: Acknowledgements: Italian Translation EBMT EBMT Nurses Group would like sincerely thank following individual Italian Nurses Group important role translating second edition EBMT Textbook Nurses: Stefano Botti Simona Calza Chiara Cannici Francesca Palmisano Giorgia Gobbi Alfonso Parisi Italian Nurses Group: Gruppo Italiano Trapianto di Midollo Osseo Nursing Group (GITMO NG) French Translation EBMT EBMT Nurses Group would like sincerely thank following individual French Nurses Group important role translating second edition EBMT Textbook Nurses: Cristina Baina Caroline Bompoint Natacha De Bentzmann Thomas Jezequel Sophie Porcheron Stphanie Schmitt Sylvie Tarillon French Nurses Group: Groupe Francophone de Infirmiers et Coordinateurs de Greffe de Moelle (GFIC-GM) German Translation EBMT EBMT Nurses Group would like sincerely thank following individual German Nurses Group important role translating second edition EBMT Textbook Nurses: Cornelia DudaOle SturmJulia MattareiMichaela KornAnke JhnkeAnke Acosta HerediaTina KaiserKathrin SchifferEva- Maria KummererRomina LangeAleksandra TrojanTalea JacobsenAngelika BiekerKatharina JalinkDaniel KisielewskiLea Papadopoulos German Nurses Group: Deutsche Arbeitsgruppe KMT / SZT der Pflegenden Spanish Translation EBMT EBMT Nurses Group would like sincerely thank following individual Spanish Nurses Group important role translating second edition EBMT Textbook Nurses: Francisco Xos Romn Losada Isabel Salcedo de Diego Eugenia Trigoso Arjona Cristina Gallego Millares Julia Ruiz Pato Spanish Nurses Group: Grupo de Enfermera del Grupo Espaol de Trasplante Hematopoytico Terapia Celular (GETH-TC) EBMT Online Learning Course Nurses EBMT Nurses e-learning program ha transformed successful EBMT Nurses Textbook ha developed nurse interest Haematopoietic Cell Transplantation. brings together knowledge nursing leader HCT nursing care provide nurse comprehensive informative guide covering aspect transplant nursing, basic principle advanced concepts. take learner journey history transplant nursing, presenting concept help nurse improve patient experience. also explores research auditing methods. ultimate goal e-learning support EBMT Nurses Group's objective improving care patient receiving HCT. EBMT Online Learning Course Nurses available e-learning platform open public. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb JACIE Accredited Centres page feature two lists. first list show centre valid accreditation (valid meaning yet expired). second list show centre formally requested accreditation stage process. includes applied, awaiting inspection, inspected awaiting report, correction phase. list make assessment centres' compliance Standards.Both list updated monthly basis. JACIE Report accredited Centers: Please note part response COVID19 pandemic, extension wa awarded once-off unique measure centre whose accreditation wa still valid 31 March 2020. extension already incorporated Accreditation time period shown Report. Accrediation award issued 1 April 2020 reverted standard 4-year period. JACIE Report Centres process: Thosecentres listed "In Process" separate list Accredited centres. referred "coverage", term limited acknowledging given centre accreditation process without achieved accreditation. letter stating current status berequested JACIE office centre writing Please note different Stages reflected list Centres Processrelate different phase Accreditation process: Stage Phase 01 Initial registration (new, unapproved) Pre-inspection phase. JACIE/Centre reviewing Application Accreditation 02 Document Checklist (new, approved) Pre-inspection phase. Centre preparing submission ofPre-audit documentation 03 Inspection Inspection phase. Centre awaiting going Inspection 04 Post-inspection (awaiting inspection report) Post-inspection phase. Inspectors working Inspection Report 05 Preparing Summary Report Post-inspection phase. JACIE Office working Inspection Report 06 Accreditation Committee Post-inspection phase. Report ready discussed/being discussed Accreditation Commtitee 07 process (not accredited) Post-inspection phase. Centre working Evidence Corrections 08 Assessment correction Post-inspection phase. Centre ha submitted Evidence correction reviewed See also FAQs section. event centre doe appear either list, please contact JACIE Office information telephone +34 93 453 8570. Follow u Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Area - -EBMT OrganizationResearchRegistry/Data ManagementNurses GroupEventsTraining/EducationAccreditationPatients & DonorsTransplant Activity Survey Group - -Acute Leukemia Working Party (ALWP)Severe Aplastic Anaemia Working Party (SAAWP)Autoimmune Diseases Working Party (ADWP)Chronic Malignancies Working Party (CMWP)Cellular Therapy & Immunobiology Working Party (CTIWP)Inborn Errors Working Party (IEWP)Infectious Diseases Working Party (IDWP)Transplant Complications Working Party (TCWP)Lymphoma Working Party (LWP)Paediatric Diseases Working Party (PDWP)Haemoglobinopathies Working Party (HWP)Registry CommitteeStatistical CommitteeJACIE CommitteeInspector CommitteeAccreditation CommitteeDonor Outcomes CommitteeQuality Managers CommitteeLegal & Regulatory Affairs CommitteeGlobal CommitteeNuclear Accident CommitteePharmacist CommitteePatient Advocacy CommitteeTrainee CommitteePractice Harmonisation CommitteeNursing Research CommitteeNursing Scientific CommitteeNursing Paediatric CommitteeNursing Global Education CommitteeEquality, Diversity & Inclusion (ED&I) CommitteeGoCART CoalitionWP/Committee specifiedOther societyActivity survey officeCOVID-19 Document type Corporate (Annual reports, minutes, ToRs, etc.)Forms, Checklists & TemplatesGuidelines, Consensus Statements & Position PapersNewsletterPress ClippingPress ReleaseProtocol/Study informationTraining/Education MaterialsTraining/Education Presentations & AbstractsUser guides/Instructions Event type - -EBMT Annual MeetingBusiness MeetingEducational MeetingTraining Course Creation date Language - -EnglishArabicCroatianCzechDanishDutchEstonianFinnishFlemishFrenchGermanGreekHebrewItalianJapaneseLithuanianMandarinNorwegianPolishPortugueseSlovenianSpanishSwedishTurkish Text Pagination Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb EBMT Organisation Board Association Anna Sureda EBMT President Congress Co-President Barcelona, Spain John Snowden Member JACIE Committee United Kingdom Mette Hazenberg EBMT Treasurer Netherlands Fabio Ciceri Scientific Council chair Research Sciences portfolio ALWP Chair Congress Co-President Milan, Italy Donal McLornan Scientific Council co-chair Research Sciences portfolio CMWP Chair United Kingdom Rafael de la Camara Registry Committee Co-Chair Madrid, Spain Raffaella Greco EBMT Secretary Italy Michelle Kenyon President Nurses Group United Kingdom Scientific Council - Working Parties Antonio Risitano SCIENTIFIC COUNCIL representative Registry portfolio SAAWP Chair Italy Raffaella Greco EBMT Secretary Italy Fabio Ciceri Scientific Council chair Research Sciences portfolio ALWP Chair Congress Co-President Milan, Italy Annalisa Ruggeri SCIENTIFIC COUNCIL representative Education portfolio CTIWP Chair PRACTICE HARMONISATION COMMITTEE VICE-CHAIR Italy Rafael de la Camara Registry Committee Co-Chair Madrid, Spain Bndicte Neven IEWP Chair France Krzysztof Kalwak PDWP Chair Poland Donal McLornan Scientific Council co-chair Research Sciences portfolio CMWP Chair United Kingdom Zinaida Peri TCWP Chair Acute Lymphoid Leukaemia Subcommittee Croatia Emanuele Angelucci HWP CHAIR Italy Michelle Kenyon President Nurses Group United Kingdom Committees Nina Worel Donor Outcomes Committee Chair EBMT Representative JACIE Committee FACT-JACIE Standards Steering Committee member Austria Per Ljungman Registry Committee Chair Honorary Member Stockholm, Sweden Norbert Claude Gorin Global Committee Chair, Chief Representative EBMT Shanghai Office AUTO-SCT graft composition subcommittee Honorary member Paris, France Ray Powles Nuclear Accident Committee Chair Honorary Member United Kingdom Nick Duncan Pharmacist Committee Chair United Kingdom Focus: pharmaceutical care, antifungal stewardship, education training, medicine adherence Natacha Bolaos PATIENT ADVOCACY COMMITTEE CHAIR Spain @BolanosNat Claire Horgan CO-CHAIRPERSON TRAINEE COMMITTEE PAEDIATRIC HAEMATOLOGY TRAINEE United Kingdom @TheEBMT_Trainee @Claire_P_Horgan Nico Gagelmann CO-CHAIRPERSON TRAINEE COMMITTEE INTERNAL MEDICINE TRAINEE Germany @TheEBMT_Trainee @NicoGagelmann Jrgen Kuball LRAC Chair Liaison European Medicines Agency, European Commission & Industry Netherlands Ibrahim Yakoub-Agha Practice Harmonisation Committee Chair France @i_yakoub_agha Silvia Montoto Equality, Diversity & Inclusion (ED&I) Committee Chair United Kingdom Lynn Manson JACIE Committee Chair Chairperson Accreditation Committee Inspector Commitee Member United Kingdom Collection Inspector Renza Monteleone QM Member JACIE Accreditation Committee INSPECTOR COMMITEE MEMBER Italy Annika Kisch CHAIRPERSON NG RESEARCH COMMITTEE Sweden Marijke Quaghebeur CHAIRPERSON NG SCIENTIFIC COMMITTEE Belgium Ida Bremer Ophorst PDWP NURSE CHAIRPERSON NG PAEDIATRIC COMMITTEE Netherlands Julia Ruz Pato CHAIRPERSON NG GLOBAL EDUCATION COMMITTEE Quality Manager & JACIE Inspector Spain EBMT Staff Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb ANBI Data Full name Institution European Society Blood Marrow Transplantation Tax identification number RSIN Foundation: 814370822 RSIN Association: 804217257 Contact detail Netherlands Rijnsburgerweg 10, 2333 AA. Leiden, Netherlands email: phone number: +31 71 526 1444 Executive Committee President: Anna Sureda Secretary: Raffaella Greco Treasurer: Mette Hazenberg policy remuneration policy Board administrative body EBMT. responsible running operation decision due taken General Assembly (see below). Board consists President, President-Elect, Secretary, Treasurer, President division EBMT Nurses Group four member elected Scientific Council. President forthcoming EBMT Annual Meeting elected onto Board year preceding annual meeting non-voting member. Decisions taken majority voting. President ha deciding vote vote otherwise tied. Members Board receive remuneration work, unless Genera Assembly Meeting decides otherwise time appointment. expense incurred reimbursed consultation Board. Please refer EBMT Foundation Constitution EBMT Association Constitution EBMT bylaw detail EBMT Policy. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Patient Privacy Statement Patient Personal Data Protection Statement European Society Blood Marrow Transplantation (EBMT) maintains international medicaldatabase known EBMT Registry. Registry go back beginning 1970s contains clinical data including aspect diagnosis, first line treatments, haematopoietic stem cell transplant (HCT) cell therapy associated procedures, complication outcome. document detail personal data EBMT collects, collected stored purpose used. also information contact registry right individual data subjects. wa generated response new legislation, General Data Protection Regulation (Regulation (EU) 2016/679, hereafter GDPR). registry considered separate type data collection privacy authorities. importance coupling information registry order obtain new knowledge great value explicitly recognized (consideration 157 GDPR). GDPR applies usage personal data research call interpreting research purpose broad manner including instance applied research (consideration 159 GDPR). Patient Data collected? EBMT Registry collect data research development new improved transplant, cell therapy immunosuppression procedures, improve quality procedure accreditation treatment units. find information EBMT study personal data might used, visiting website following page: personal data obtained? EBMT work partnership local healthcare provider collect data patient undergoing bone marrow stem cell transplantation, cell therapies, immunosuppressive treatment disease. Following GDPR, ensure maximum accordance law EU/EEA nations, personal data patient residing EU member country shall used research EBMT appropriate informed consent ensured. ha common practice many year already. informed consent collected individual centre donor registry submitting data EBMT make certain respective national law followed. EBMT make patient consent prerequisite submitting data provides necessary information usage data, ensure appropriate consent obtained cases. personal data sent EBMT Registry? Data collected identify person limited hospital UPN (Unique Patient Number), patient initials, date birth, gender. item minimal personal data necessary ensure medical data collected different time accurately stored record. used identification individual stored separately enhanced security. process separate storage known pseudonymisation[i] defined GDPR regulations. patient report given unique non-informative database number (Unique Identity Code) one used research purposes. minimum amount patient personal data necessary type registries, contributing accuracy data, therefore contributing improvement care outcome. personal data processed? EBMT ensures personal data responsibility processed according GDPR: Processed lawfully, fairly transparent manner relation data subject; Collected scientific research legitimate purposes; Processed adequately, relevantly limited necessary relation purpose collected and/or processed; Accurate date; Kept unlimited period form permit identification data subject purpose historical, statistical scientific research purposes; Processed manner ensures appropriate security personal data technical organisational measures. Personal Data Stored? data stored electronic database located European country. European country follow GDPR, regardless whether member European Union not, host data. database protected safeguard ensure security, including compliance NEN7510/ISO27001 certification. data accessible EBMT employee performance job following stringent access control policy Personal Data Transfers EBMT work many researcher international collaboration across scientific clinical institution so, previously gathered consent, patient pseudonymised personal data may sent tocountries outside EEA areprovided level protection privacy. Medical data sent outside area context EBMT research project identified non-informative database number, item date birth, initial hospital UPN exported. EBMT sell, distribute lease personal data third party unless data subject ha provided EBMT consent allowed law. Rights Data Subjects? Data Subject ha right following information personal data processed: Confirmation whether data related processed; Information purpose processing operations, category data concerned, recipient category recipient data disclosed; Communication data undergoing processing. Data Subject shall right listed below: Access information processed personal data; Rectification inaccurate incomplete personal data; Withdraw consent personal data longer made available future research; Request personal data completely erased EBMT Registry database database data ha exported; right granted Data Subject regard personal data, respective local legislation. Data Subject wish exercise right listed above. Please send email use postal address below. Data Protection Officer Edifici Dr. Frederic Duran Jord Passeig Taulat, 116 08005 Barcelona (Spain) Data Subject also ha right lodge complaint supervisory authority. Comments question comment question patient personal data protection statement, please send [i] Pseudonymisation -the processing personal data manner personal data longer attributed specific data subject without use additional information, provided additional information kept separately subject technical organisational measure ensure personal data attributed identified identifiable natural person.Article 4 sub (5) GDPR. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Privacy Policy EBMT (European Group Blood Marrow Transplantation) committed user privacy. EBMT website - ha structured user visit without identifying revealing personal information. personal data user may decide provide u used support relationship EBMT user. personal data? Personal data information relating identified identifiable natural person ('data subject'); identifiable natural person one identified, directly indirectly, particular reference identifier name, identification number, location data, online identifier one factor specific physical, physiological, genetic, mental, economic, cultural social identity natural person. personal data obtained? EBMT collect personal data voluntarily submit completing on-line forms. choose submit personally identifiable information EBMT, latter use information purpose consented. purpose processing personal data detailed on-line form application form. personal data processed? EBMT ensures personal data responsibility processed according General Data Protection Regulation (GDPR 2016/679) Processed lawfully, fairly transparent manner relation data subject; Collected legitimate purposes; Processed adequately, relevantly excessively relation purpose collected and/or processed; Accurate date; Kept form permit identification data subject longer necessary purpose personal data processed. Processed manner ensures appropriate security personal data technical organisation measures. Personal Data Transfers EBMT sell, distribute lease personal information third party unless permission required law so. EBMT work many Collaboration Partners internationally including national registries, national health authorities, researcher scientific/clinical institution marketing authorisation holder (MAHs; Pharmaceutical company owning therapy patient may receive treatment) clinical research purpose development new improved transplant, cell therapy immunosuppression procedures, improve quality procedures. purpose described order comply legal obligation requirement development clinical research studies, data might shared MAH national health authority context study institution part of. Personal Data Stored? Personal datais stored electronic databaseproperty EBMT allocatedin EEA (European Economic Area) country provided level protection privacy. right Data Subject? Data Subject ha right following information personal data processed: Confirmation whether data related processed; Information purpose processing operations, category data concerned, recipient category recipient data disclosed; Communication data undergoing processing. Knowledge logic involved decision process concerning use data subject personal data. Data Subject shall right listed below: Access information processed personal data. Rectification inaccurate incomplete personal data. Withdraw consent personal data longer processed. Request personal data completely erased EBMT database database data ha exported. Data Subject wish exercise right listed above. Please send email toor use postal address below. Data Protection Officer Edifici Dr. Frederic Duran Jord Passeig Taulat, 116 08005 Barcelona (Spain) Data Subject also ha right lodge complaint supervisory authority. Comments question comment question privacy policy, please send Data Protection Officer Edifici Dr. Frederic Duran Jord Passeig Taulat, 116 08005 Barcelona (Spain) collect Web Statistics browse Web site, EBMT collect non-personally identifiable data, as: type browser used access site date time visit page visited address Web site referred clicked link get site EBMT collect information statistical purpose evaluating Web site make useful visitors. cookie small file asks permission placed computer hard drive. agree, file added cookie help analyse web traffic let know visit particular site. Cookies allow web application respond individual. web application tailor operation needs, like dislike gathering remembering information preferences. choose accept decline cookies. web browser automatically accept cookies, usually modify browser setting decline cooky prefer. may prevent taking full advantage website. provide link website website may contain link website interest. However, used link leave site, note control website. Therefore, cannot responsible protection privacy information provide whilst visiting site site governed privacy statement. exercise caution look privacy statement applicable website question. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Cookie Policy EBMT would like inform collection processing cookies. cookies? cookie small file asks permission placed computer hard drive. agree, file added cookie help analyse web traffic let know visit particular site. Cookies allow web application respond individual. web application tailor operation needs, like dislike gathering remembering information preferences. type cooky doe website use? Analytical cooky - well treated u third parties, allow u quantify number user thus carry statistical measurement analysis use made user service offered. this, browsing website analyzed order improve offer product service offer you. Third-party cookies: allow number user quantified thus carry statistical measurement analysis use made user service offered. this, browsing website analyzed order improve offer product service offer you. website us third-party service collect information statistical purpose use website: Google Analytics: (Analytical Cookies). disable cooky allow, block delete cooky installed computer configuring browser option installed computer. access configuration frequent web browser accept, install deactivate cookies: Firefox Safari Google Chrome provide link website website may contain link website interest. However, used link leave site, note control website. Therefore, cannot responsible protection privacy information provide whilst visiting site site governed privacy statement. exercise caution look privacy statement applicable website question. Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Terms Use continue browse use website, agreeing comply bound following term condition use, together privacy policy govern EBMTs relationship relation website. disagree part term conditions, please use website. term EBMT (European Group Blood Marrow Transplantation) u refers owner website whose registered office P.O. Box 3151, 6202 ND Maastricht, Netherlands. company registration number 41166105. term refers user viewer website. use website subject following term use: Scope website content page website general information use only. subject change without notice. Accuracy material EBMT make best effort keep material web site date accurate. general errors, editorial error detected EBMT make best effort correct appropriate. Documents published indicated, sometimes might final formally accepted version. specific advice Nothing web site considered constitute advice specific cases, including medical advice, unless stated otherwise. Use material Neither EBMT person acting behalf responsible use might made information contained web site. EBMT assumes responsibility regard use material available web site. Users act risk using material web site hereby urged take necessary precaution evaluating usefulness applicability material intended purposes. Technical error spite EBMTs best efforts, sometimes technical error might occur. EBMT doe warrant error-free operation material appropriate publishes web site. EBMT accepts responsibility liability whatsoever regard material accessed, operated downloaded web site. Copyright Material includes data, text, software multimedia, image sound might made available publicized EBMT web site. Reproduction material published web site authorized, provided source acknowledged, unless stated otherwise. prior permission must obtained reproduction use material published web site mentioned permission shall cancelled restriction shall imposed legal notice appropriate published specific material. Enquiries regarding authorization reproduction sent . reproduction EBMT logo permitted provided source acknowledged logo used press medium related purposes. us prohibited unless permission requested. Links website website includes link websites. link provided convenience provide information. signify endorse website(s). responsibility content linked website(s). Secondary 2024 EBMT. right reserved. Footer menu Shortcuts Search Main navigation Menu Breadcrumb Contact u browser doe support iframes, visit Secondary 2024 EBMT. right reserved. Footer menu